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 The biological response of cells to mechanical forces is integral to both normal 
cell function and the progression of many diseases.  Physical cues experienced by cells 
arise from internally generated contractile forces, as well as from external sources of 
force and strain in the local environment. We have used arrays of flexible micron-scale 
poly(dimethylsiloxane) (PDMS) cantilevers (posts) to probe the behavior of cell-
generated contractile forces under varying chemical and mechanical conditions. The 
cells’ contractile forces displace the tops of the underlying posts, which are individually 
tracked through microscopy and image analysis, yielding a dynamic, micron-scale map of 
the cells’ mechanical activity. I have applied these techniques to study cell generated 
forces in two experimental systems.  First, force generation by cardiac fibroblasts (CFs) 
in order to elucidate mechanical coupling between these cells and the myocytes 
responsible for the heart’s pumping action, which may contribute to certain types of 
cardiac arrhythmias.  These experiments were part of a collaborative effort which 
demonstrated that modulation of both CF contractile forces, and the cellular structures on 
which these forces can act when coupled to cardiac myocytes, had direct influence on the 
electrical conduction mechanisms that are critical for the proper functioning of cardiac 
muscle tissue.   
iii 
 
The second experimental system studied the impact of force application through 
an applied global stretch on the traction force dynamics of arterial smooth muscle cells. 
These cells, resident within the inner walls of arteries, are constantly exposed to global 
stretching forces as a result of changes in blood pressure and flow.  I developed an 
enhanced version of the micropost array that enabled the application of controlled global 
stretch to cells while the evolution of traction forces could be measured in real time.  
These measurements revealed a heterogeneous response to imposed strain, as a portion of 
the tested cells responded by increasing their force generation against the micropost 
substrate, while others underwent plastic deformation and exhibited relatively small 
changes in force generation.  Upon reversal of stretch direction, all cells exhibited 
decreasing force generation that is characteristic of a viscoelastic response.  Following 
stretch completion and left at rest, all cells demonstrated active recovery and re-
establishment of contractile forces.   
I have also demonstrated the combined use of a laminar flow technique, 
micropipette “spritzing”, with both micropost arrays and microfabricated tissue gauges 
for application of local chemical stimulation to single cells or single tissues while 
observing contractile dynamics in real time.   
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Chapter 1 Introduction 
Biological systems, from ecological networks down to single cells, represent a 
critical frontier in our understanding of the universe.  At the scale of a single cell, these 
systems, while vast in complexity, must operate on the basis of physical laws governing 
the interactions of single molecules.  Studying these systems at mesoscopic (cellular/sub-
cellular) scales provides insight into the emergence of biological function from these 
fundamental interactions.  As tools to further our understanding, microengineered devices 
are advancing our ability to not only probe and measure the properties of living cells and 
tissues, but to selectively alter and control the microenvironment for targeted studies of 




1.1 Cellular Structure and Force Generation 
1.1.1 Cellular Structure 
 The primary physical structure that establishes the mechanical properties of a 
biological cell is the cytoskeleton.  The cytoskeleton is a filamentous network that 
supports the cell and defines the structure and shape.  There are three main types of 
filaments that comprise the cytoskeleton.  The largest, microtubules, are hollow cylinders 
~23 nm in diameter.  Microtubules play important roles in the intracellular transport of 
organelles, and are perhaps best known for their role in the formation of the mitotic 
spindle and chromosome separation during cell division.  Intermediate filaments, ~10 nm 
in diameter, serve to anchor organelles, supply structural support for the nuclear lamina, a 
fibrous network inside the cell nucleus, and support cell shape.  The third type of 
cytoskeletal filaments are microfilaments.  Often referred to as actin filaments (f-actin), 
due to their being comprised of polymerized actin subunits known as globular actin, or g-
actin, these filaments are ~6 nm in diameter and are highly dynamic.  Actin filaments 
span the entire cell, providing structure and mechanical support (Fig 1.1).  Actin filament 
dynamics are regulated by processes that serve to polymerize, or grow, what is known as 
the “barbed” end of fibers, and depolymerize subunits at the “pointed” end.  The relative 
rates of these two processes play a primary role in driving morphological changes and 
cell motility, and are regulated by cell signaling mechanisms.  The action of proteins such 
as the actin severing protein cofilin, which cleaves actin subunits from the pointed end,  
or profilin, which promotes polymerization at the barbed end, are regulated to facilitate 




Figure 1.1: (A) Phase contrast image of a NIH 3T3 fibroblast cultured on a two 
dimensional substrate.  (B) Fluorescence image of the same cell showing actin fibers 
labeled using Alexa-Fluor 488 Phalloidin.  
1.1.2 Force Generation  
Actin filaments are the primary medium through which cells are able to generate 
force.  Actin polymerization at a cell’s leading edge generates outwardly directed force 
that facilitates the formation of cellular protrusions known as pseudopodia, and coupled 
with actin depolymerzation at the trailing edge, enables a cell to undergo amoeboid 
movement, or “crawling” within its environment.  More predominantly, the actin network 
enables a cell to generate inwardly directed contractile forces.  This is achieved through 
the action of mysosin motors, which are specialized proteins that bind to and cross-link 
actin filaments.  Adenosine tri-phosphate (ATP) hydrolysis produces the necessary 
energy for conformational changes in actin bound myosin that enable the myosin to move 
or “walk” along the filaments.  Through this mechanism myosin motors generate a 
relative sliding motion between cross linked actin filaments (Fig 1.2).  This system for 
generating force is commonly referred to as the “acto-myosin” system[1].  Regulation of 
the acto-myosin system in non-striated muscle tissue is predominantly controlled by the 
Rho family GTPase, RhoA.  GTPases are protein complexes that function as molecular 
switches for controlling signaling processes. They are turned on and off through 
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hydrolysis of guanosine triphosphate (GTP), a source of energy within cells that is similar 
to ATP.  Through this switching mechanism, RhoA phosphorylates, or activates, the 
protein ROCK.  ROCK then inhibits myosin light chain (MLC) phosphatase, which when 
uninhibited serves to decrease myosin activity, leading to increased myosin activity and 
increased contraction. [2].          
 
 
Figure 1.2: Schematic of myosin motor proteins (blue), crosslinking two acti fibers (red) 
for generation of relative sliding motion (arrows) [2]. 
   
The binding of myosin to actin, a necessity for generation of contractile force, is 
largely dependent on the concentration of intracellular calcium, particularly in skeletal 
and cardiac muscle cells.  In the absence of calcium, myosin binding sites located on 
actin fibers are blocked and the myosin head is unable to bind to and cross link actin 
fibers.  The protein complexes that block these binding sites, tropomyosin in particular, 
undergo conformational changes as a result of binding calcium.  These changes expose 
the myosin binding site on the actin fibers allowing myosin to bind and cross link the 
fibers, ultimately facilitating the generation of contractile force [1].  In this way, 
regulation of intracellular calcium can regulate the contractile state of a cell.  In cardiac 
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muscle, for instance, the regulation of calcium through transmitted electrical signals is 
what triggers the contraction of cardiac muscle [3].   
 
1.2 Cell Adhesion 
A cell’s acto-myosin system is bound, or anchored, to adhesion sites located near 
the cell’s periphery.  These adhesion sites are connected to proteins that span the width of 
the cell membrane, known as trans-membrane proteins, which are capable of binding to 
structures exterior to the cell.  Different types of adhesive junctions exist to provide 
cellular attachment to either the extra cellular matrix, or to other cells.  In addition, there 
are different types of cell-cell junctions that enable specialized interactions between cells. 
1.2.1 Cell-Substrate Adhesion 
The extracellular matrix, or ECM, is a complex structure that occupies the 
intercellular space, consisting in part of structural proteins (collagens, elastins) that 
provide mechanical support, and adhesive proteins (fibronectin, laminins) for cellular 




Figure 1.3: Schematic of two cells adhered to each other and the surrounding extra 
cellular matrix (ECM) within a tissue[4]. 
 
Trans-membrane proteins that serve to link the cytoskeleton with the surrounding 
ECM are known as integrins.  The portion of  integrins that is external to the cell varies in 
structure based on the type of ECM protein it is designed to bind with, and while the 
internal portion has specific binding sites for attachment to the cytoskeleton, this portion 
can also vary in structure based on the cell type in which it is located [1, 5].  Linkages 
between integrins and the cytoskeleton occur at adhesive junctions known as focal 
adhesions, or more dynamic focal complexes.  Focal adhesions consist of a variety of 
adapter proteins (vinculin, α-actinin, talin) that are responsible for direct binding of 
integrins to the actin cytoskeleton, as well as signaling proteins (e.g. focal adhesion 
kinase) for dynamic regulation[6].  Figure 1.4 shows fluorescently labeled vinculin 
present within a pair of smooth muscle cells cultured on a two dimensional substrate, 






Figure 1.4: (A) Schematic of a cell with cytoskeleton adhered to ECM via focal 
adhesions [7]. (B) Fluorescence image of smooth muscle cells cultured on a two 
dimensional substrate.  Fluorescently labeled vinculin (light patches) indicates the 






1.2.2 Cell-Cell Adhesions 
Similar to integrins and focal adhesions, adhesive junctions between neighboring 
cells rely on trans-membrane proteins called cadherins.  The inner portion of cadherins 
link to the actin cytoskeleton using similar adapter proteins found in focal adhesions, 
whereas the outer portion binds to other cadherins presented on the membrane surface of 
other cells (Fig 1.5). 
 
Figure 1.5: Schematic diagram of an adherens junction showing cadherin-mediated 
attachment between cytoskeletal actin filaments of two adjacent cells.  (Image by 




Other types of cell-cell junctions include “tight junctions”, which form between 
adjacent cells and bring the membranes in close enough proximity to prevent fluid flow 
in the intercellular space [1].  The third type of cell-cell junctions are gap junctions, 
formed by trans-membrane proteins called connexins.   Connexin monomers cluster 
together to form hollow cylinders that allow for the passage of small ions and molecules 





Figure 1.6: Schematic diagram of  gap junctions between two plasma membranes.  
Connexin monomers form hollow, cylindrical channels allowing for the passage of small 





1.2.3 Mechanotransduction, Cell Behavior, and Pathology  
Sites of cellular adhesion provide, through linkage to the acto-myosin system, the 
means for cells to apply force to their external environment.  These same adhesion sites 
also serve as a means of transmitting forces imposed on the cell from its environment to 
the cytoskeleton.  The process through which a cell transduces, or converts, a mechanical 
stimulus into a biochemical signal or, more generally, cellular action, is termed 
Mechanotransdution.  The interplay between both force generation and force sensing with 
focal adhesion dynamics has been observed in studies that demonstrated that the 
application of mechanical stress was required for maturation of focal complexes into 
focal adhesions [8], and that regulation of RhoA facilitated focal adhesion assembly, as 
well as actin stress fiber formation .   More recently, acto-myosin generated forces acting 
at adherens junctions have been measured in patterned endothelial cell pairs, and found to 
regulate adherens junction size [9].   
Not only do mechanical forces influence the regulation of cellular adhesions, 
mechanical stimuli have been shown to affect a broad range of cellular processes and 
behaviors.  Endothelial cells can be influenced to either proliferate, or undergo 
programmed cell death (apoptosis) depending on available spreading area [10].  Both the 
rate [11] and direction [12] of cell migration can be influenced by geometric properties of 
the ECM.  As well, mechanical stresses are known to contribute to the progression of 
many diseases [13].  For example, the response of endothelial cells to fluid flow shear 
stress contributes to atherosclerosis progression [14] , and specific lines of melanoma 




1.3 Model Systems and Experimental Overview 
Despite advances in our understanding of the molecular basis for force generation 
and mechanotransduction in cells, the ways in which these molecular level phenomena 
are translated into whole-cell forces and dynamics are still not well understood.  In order 
to identify potential targets for treatment of mechanically mediated diseases, it is critical 
that our understanding of the mechanotransduction process continues to advance.  
Targeted studies that focus on carefully chosen model systems are particularly useful in 
that they allow for investigation of biological function and response that is directly tied to 
their in vivo functionality.      
I have studied cellular force generation in two model systems, the first of which 
consisted of neonatal rat ventricular fibroblasts (CFs) in order to study mechanical 
coupling between CFs and cardiac myocytes.  The muscular tissue in the heart, known as 
the myocardium, is responsible for contraction and initiation of blood flow.  Electrical 
signals initiated in the sinoatrial node propagate through the myocardium, facilitating the 
coordinated beating action of the tissue.  The two main cell types [16] resident in the 
myocardium are cardiomyocytes, the functionally contractile cells responsible for 
beating; and cardiac fibroblasts (CFs), which are responsible for production and 
remodeling of the extra cellularmatrix (ECM), particularly during wound healing [17], 
and have more recently been implicated in processes such as cell signaling, heterocellular 
coupling, and mechanoelectric feedback [16].  Cardiac myocytes are coupled to one 
another via electrical gap junctions that allow for the passage of electrical signals from 
cell to cell.  As ions flow across gap junctions, the cell membrane becomes electrically 
depolarized from its resting, negative voltage state.  This depolarization triggers the cell 
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to rapidly generate strong transient contractile forces, causing an effective “beat” as the 
entire cell body contracts and then returns to rest.   
Following cardiac injury, such as infarction, cardiac fibroblasts migrate to the 
region of injury in order to replace necrotic tissue with new ECM (scar tissue), and to 
generate sustained contractile forces in order to minimize the scar area.  To facilitate this 
functionality, cardiac fibroblasts differentiate into cardiac myofibroblasts (CMFs), a more 
contractile phenotype capable of generating high magnitude tonic contraction forces [18-
20] .  Due to their coexistence in cardiac muscle, understanding heterocellular coupling 
of cardiac myocytes and CFs is critical to our knowledge of heart physiology.  
Experiments in chapter 3 of this work directly measured the contractile force generation 
of cardiac fibroblasts (CFs) under a variety experimental conditions chosen to elucidate 
the role of mechanical coupling between cardiac fibroblasts and cardiac mycoytes on the 
physiology of cardiac tissue.  CF contractile forces were measured using arrays force 
sensing microposts, originally developed by Tan et al., which enable direct measurement 
of contractile forces generated by a cell’s acto-mysoin system [21]. 
The second model system studied application of stretch to bovine pulmonary 
artery smooth muscle cells (BPASMCs).  The middle layer of blood vessels, known as 




Figure 1.7: Schematic cross section of an artery, showing the location of smooth muscle 
cells in the arterial wall [22].  
 
   The tunica media is integral in the regulation of blood pressure and flow due to its 
role in controlling blood vessel diameter [23].  Because of this, the arterial SMCs and 
surrounding matrix are exposed to external global stretching forces caused by changes in 
blood pressure.   In order to establish a more complete understanding of blood vessel 
physiology, it is therefore necessary to understand how the cells and tissue that form 
blood vessels respond and adapt in such a mechanically dynamic environment.  To this 
end, I have developed an experimental procedure, described in chapter 4, using a custom 
cell culture device capable of applying stretch to a flexible membrane, upon which is 
micropost arrays were fabricated.  These experiments enabled the measurement of cell 
generated traction force dynamics during application of global stretch to BPASMCs.     
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 Chapter 5 demonstrates the combination of a local chemical stimulation technique 
using glass micropipettes with the aforementioned micropost device, as well as a device 
for measuring force generation in microtissue constructs[need first TUG paper ref].     
 
1.4 Dissertation Outline 
In Chapter 2, methods and experimental techniques for the fabrication, 
preparation, and analysis of force sensing devices are described.  Included is a description 
of modifying these devices for use on a flexible substrate and of the custom designed 
culture chamber used for application of stretch.  In Chapter 3, the results from studies of 
cardiac fibroblast force generation are presented, along with data showing the impacts of 
this force generation on the proper functioning of model cardiac tissues.  Chapter 4 
describes methods and results of application of global stretch stimulus to BPASMCs 
using modified force sensing devices.  In Chapter 5, the use of an experimental technique 
combining microfabricated devices and micropipette assisted fluid flow for local 
chemical stimulation is demonstrated.  In Chapter 6 a concluding discussion of all results 









Chapter 2 Methods 
 
2.1 Introduction 
 The specialized devices, techniques, and procedures utilized in the experiments 
throughout this work are described below.  Cells were cultured and manipulated using 
standard bio-analytical techniques.  Micropost arrays were fabricated via replica molding 
from a silicon master.  A custom stretch chamber of my design was manufactured by the 
JHU machine shop.  Flexible membranes were cast using culture plates as molds.  Images 
of micropost arrays were acquired via microscopy and analyzed for quantification of 
cellular traction forces.  
2.2 Cells 
 The cells used in the experiments shown in Chapters 4 and 5 were bovine 
pulmonary artery smooth muscle cells (BPASMCs).  These cells were provided by the 
lab of Christopher Chen at the University of Pennsylvania.  The cells used for the cardiac 
experiments in Chapter 3 were neonatal rat ventricular fibroblasts.  These cells were 





 All cells used were cultured in low glucose Dulbecco’s Modified Eagle Medium 
(DMEM) containing 1% Penicillin-Streptomycin (antibiotic) and 10% Bovine Serum.  
BPASMCs were kept in culture at 37C and 10% CO2, cardiac fibroblasts were kept at 
37C and 5% CO2. BPASMCs were passaged at a ratio of 1:4 when they reached 90%-
100% confluence, and kept for use in experiments until they reached passage number 18.  
Cardiac cells were kept and used until pass 3, and were passed at a ratio of 1:10 upon 
reaching 90%-100% confluence. 
2.1.2 Fluorescence Labeling 
 In order to better locate and visualize cells cultured on micropost arrays, cardiac 
fibroblasts were fluorescently labeled in a 5μM solution of CellTracker Green CMFDA 
(Invitrogen, Carlsbad, CA) for 45 minutes, followed by a 1 hour recovery period.  
BPASMCs were similarly labeled using a 2μM solution for 30 minutes followed by a 1 
hour recovery period.  In order to determine cell number in BPASMC pair experiments, 
cell nuclei were fluorescently labeled using Hoechst nuclear stain at a concentration of 









Figure 2.1: Fluorescence image of BPASM cell pair.  Cell cytoplasm is visible in green, 
and the cell nuclei are in blue. 
 
2.1.3 Virus Transfection 
Up-regulation of myosin II activity was achieved by transfecting BPASMCs with 
RhoV14 adenovirus.  Adenovirus containing RhoV14 was produced in the lab of Chris 
Chen.  Virus treatment resulted in the production of mutant RhoA that was locked in its 
activated state.  The abundance of activated Rho created up-regulation of myosin II 
activity [24].  Control cells were transfected with a GFP adenovirus, which caused treated 
cells to express green fluorescent protein (GFP), and therefore to be visible using 
fluorescence microscopy (Figure 2.2).  BPASMCs were grown in 12-well culture plates, 
and the media was replaced with 0.5ml of media containing 2μl of Adeno-RhoV14 or   
0.5 μl of Adeno-GFP and incubated for 20 hours.  After the incubation period the cells 
were trypsinized and seeded onto mPAD substrates. The virally delivered Rho-V14 
genetic sequence also contained sequencing for production of GFP, to be used as visual 
confirmation of successful transfection.  In practice, the efficiency of GFP expression 
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was not sufficient at providing visual confirmation of virus transfection.  Therefore, cells 
were exposed to a large concentration of Adeno-RhoV14 in order to ensure sufficient 
exposure.  Experiments using these cells had to be performed within 18-24 hours after 
virus incubation in order to observe virus effects before the occurrence of over-
expression of RhoA, which would have resulted from the high levels of exposure used 
and inhibited the cells’ ability to spread on the substrate beyond useable limits.  
Fluorescence expression for Adeno-GFP transfected cells worked as intended, and did 
not require exposure of control cells to overly large concentrations of virus.  However, 






Figure 2.2:  Phase contrast (A), and fluorescence (B) images of an adeno-GFP transfected 





2.2 Device Fabrication 
2.2.1 Micropost Array Detectors  
Fabrication and preparation of micropost array detectors (mPADs) for 
experiments was adapted from published techniques [21, 25].  Micropost arrays masters 
created in silicon via deep reactive ion etching were obtained from the lab of Christopher 
Chen at the University of Pennsylvania.  Micropost array negative molds were then cast 
from the silicon masters using Polydimethylsiloxane (PDMS) (Sylgard 184,Dow 
Corning) mixed at a ratio of 1:10 curing agent to base polymer.  Positive geometry 
PDMS post arrays used for cell culture were then cast from the negative molds.  In order 
to render the negative mold surface non-adhesive to further application of PDMS, the 
molds were treated with air plasma at 100W for 90s and then coated with a 20 µl of 
(Tridecauoro-1,1,2,2-Tetrahydrooctyl)-1-Trichlorosilane (United Chemical 
Technologies) via evaporation in a vacuum dessicator for 18 hours.    This allowed for 
easy removal of the post array substrate from the mold.  Post array substrates were built 
on a glass base using #2 thickness (0.19-0.23mm) cover glass.  This thickness allowed for 
easy sample handling and was sufficiently thin for use with long working distance 
objectives.  (For use with oil/water or otherwise short working distance objectives, #1 
thickness (0.13-0.16mm) cover glass should be used.)  The cover glass was UV-Ozone 
treated (Jelight UVO-Cleaner model #42) for 7 minutes at 28 ~ 32 mW/cm² @ 253.7 nm 
to render the surface adhesive to PDMS. A 50 μl drop of 1:10 PDMS was placed onto the 
negative mold surface and then inverted onto the treated glass surface.  Substrates were 
then cured for 24 hours at 80C in air.  In order to prevent collapse of the posts upon 
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removal of the negative mold, the substrates containing the post arrays were submerged 
in 100% ethanol prior to removal of the negative mold.  Once the post array was 




Figure 2.3: Schematic of micropost functionalization and cell seeding. (A) microcontact 
printing of ECM onto micropost tops, followed by adhesion inhibitor.  (B) Cells in 
suspension seeded onto functionalized arrays.  (C) Cells will attach and spread after a 





 PDMS post arrays required functionalization in order to be suitable for cell 
culture (Figure 2.3) [25].  To create a surface that promoted cellular adhesion, the 
extracellular matrix (ECM) protein fibronectin was stamped onto the post tops via micro-
contact printing (Figure 2.3 A).  The stamping technique was used to ensure that only the 
tops of the posts were coated and not the entire substrate.  Before micro-contact printing 
could be performed, the post arrays had to be dried.  If left to dry in air, surface tension 
from the evaporating ethanol would cause the posts to collapse.  Therefore, the arrays 
were dried in a critical point dryer (Tousimis, Rockville MD) that promotes spontaneous 
evaporation.  Briefly, the ethanol was replaced with liquid CO2, which was then brought 
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to its critical point and converted into a dense gas.  Once the gas was released the posts 
were dry and ready for stamping.  
 For the stamping process, stamps made from 1:30 PDMS were coated with 100µl 
of 50ng/ml fibronectin solution in deionized (DI) water, and left for one hour.  During 
this time, a layer of fibronectin adsorbed onto the stamp surface, which was then gently 
dried with compressed nitrogen.  Post arrays were treated with UV-Ozone for 7 minutes, 
and the fibronectin coated stamps were gently placed onto the top of the array and left in 
contact for approximately 30 seconds.  Following stamping, the post substrate was 
submerged in a 1:10 solution of phosphate-buffered saline (PBS) and Pluronic F-127 
(BASF).  Pluronic F-127 is a co-block polymer that adsorbed to the surface of the PDMS 
everywhere that did not already contain ECM.  The result of these two treatments was a 
substrate that promoted cellular adhesion onto the post tops, while preventing attachment 
along the post sides or at the base of the array.  Figure 2.4 shows a phase contrast image 
of a BPASMC adhered to an mPAD.   
If fluorescently labeled posts were desired, the arrays could be submerged prior to 
cell seeding in a 1:10 solution of 50ng/ml Rhodamine B and DI water.  Rhodamine B is a 
small (479 molar mass) hydrophobic fluorescent dye, which diffuses into the PDMS 
posts rendering them visible via fluorescence microscopy.  Rhodamine B is preferable to 
other fluorescent molecules, such as the cell membrane stain DiI, which have been used 
previously [21, 25], as over time DiI will diffuse out of the posts and into the attached 
cell membranes, limiting post visibility.  Although Rhodamine B will not diffuse into 
attached cells, this style of treatment resulted in staining of all parts of the PDMS array.  
Due to the finite depth of field associated with our long working distance objectives, the 
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complete fluorescence coverage results in some level of background fluorescence from 
the bodies of highly deflected posts.  In order to eliminate this background fluorescence, 
attempts were made to label only the post tops using fluorescently labeled gelatin, which 
is a fragment of collagen that possesses multiple binding sites for fibronectin [26].  
However, upon using fluorescent gelatin, it was found that concentrations well above 





Figure 2.4: Phase contrast image of a BPASMC spread on the surface of a micropost 
array.  The boundary of the cell can be seen as a white border, and is indicated in this 





2.2.2 Flexible mPADs 
 In order to apply strain to adhered cells while simultaneously measuring traction 
forces, PDMS post arrays were constructed on flexible PDMS membranes for application 
of stretch (Figure 2.5).  PDMS was used to fabricate the membranes that served as the 
base for the arrays because uncured PDMS (that is not silane treated) will completely 
fuse with new PDMS upon curing.  Therefore, post transfer from negative molds to 
PDMS membranes resulted in a single PDMS substrate with no risk of the posts 
delaminating from the membrane surface during stretch application.  PDMS membranes 
were made using the wells of a standard 6-well cell culture plate as molds.  These wells 
have a diameter of 3.5 cm, and application of 0.5 ml 1:20 PDMS resulted in a membrane 
with a central region approximately 300µm thick.  A ratio of 1:20 was chosen in order to 
produce a more flexible substrate for application of vacuum induced deformation.  Once 
the membranes were cured, flat nosed tweezers were used to detach the sides of the 
membranes from the walls of the 6-well plate, followed by gently peeling the membranes 
out of the wells.  To assist in de-molding and prevent membrane tears, the wells were 
filled with enough ethanol to cover the membrane surface.  Once removed, membranes 
were cut to size using a custom built die 13/16” (2.06 cm) in diameter.  Membranes were 
trimmed in order to allow for loading into the critical point dryer used for substrate 
drying after post application.   
Trimmed membranes were then placed into a flat sample container and micropost 
arrays were constructed on the top surface using 1:10 PDMS and negative molds, using 
the same procedure for posts constructed on a glass substrate.  After curing, substrates 
were submerged in ethanol prior to removal of molds and critical point drying.  With 
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some modification, the same functionalization process described above was used for 
flexible mPADs constructed on membranes.  With the entire substrate constructed from 
PDMS, the flexible mPADs were too buoyant to reliably remain submerged while 
treating and washing with water based solutions.  This issue was resolved by using 
hollow PDMS cylinders placed on top of the membranes, around the post arrays.  These 
cylinders stuck to and partially sealed with the membrane, allowing for solution to be 
placed inside the cylinder body, over the top of the post array.  PDMS cylinders were 
fabricated by placing test tubes 1.5 cm in diameter vertically in a Petri dish, which was 
then filled with 1:10 PDMS and cured.  After curing, a razor blade was used to cut 
cylinders from the bulk PDMS using the holes from the test tubes as the cylinder centers.  
While not critical, the cylinder walls were generally cut to be approximately 5 mm thick. 
Notably, it was not possible to use fluorescent labeling of the microposts on the 
flexible substrates.  The membranes used for stretching were in contact with sterile 
vacuum grease during cell seeding and experimentation (see Section 2.23 below).  Due to 
the hydrophobic nature of Rhodamine B and other suitable molecules used for staining 
PDMS, diffusion out of the PDMS posts and into the grease occurred very rapidly, 
causing highly decreased post visibility.  To avoid this, methods of data acquisition using 















Figure 2.5: Two dimensional (A) and three dimensional (B) schematics of a cell adhered 
to a flexible mPAD.  (C) Phase contrast images of a flexible mPAD before and after 









2.2.3 Stretch Culture Chamber 
 
 
Figure 2.6: Flexible mPAD stretch culture device. (A) Schematic of device showing 
upper and lower pieces with membrane and media location. (B) Bottom view of the top 
piece of the chamber showing the vacuum chamber that surrounds the central well and an 
O-ring to seal the membrane edges. (C) Bottom view of the whole device with flexible 
mPAD. (D) Top view of device with flexible mPAD. 
 
 
   Application of stretch to cultured cells required a means to apply strain to a 
flexible culture substrate while maintaining suitable culture conditions and allowing for 
extraction of data.  This was achieved through design of a custom-built culture chamber 
in which the flexible culture substrates described above were mounted and stretched 




hole 0.5 inches in diameter surrounded by a cylindrical vacuum chamber 0.5 inches tall 
and 0.1675 inches wide.  Once mounted, the PDMS membrane served as the base of a 
central “culture well” that was open for viewing on an inverted microscope.  The stretch 
chamber was first fabricated from stainless steel, with later productions using 
polycarbonate, which was more cost efficient to manufacture.   
Substrate stretch was achieved through application of vacuum pressure via a 
programmable syringe pump to the portion of the membrane surrounding the central 
culture well that was exposed to the vacuum chamber.  In order to allow the membrane to 
slide across the base of the central cylinder during strain, a small amount of vacuum 
grease (Corning), autoclaved to ensure sterility, was applied to the bottom rim of the 
well.  Grease application also served to seal the central chamber, allowing for 
containment of culture media.  During cell seeding and prior to connecting the stretch 
chamber to a syringe pump, the stretch chamber had to be stored in such a way that the 
membrane was forced to remain in contact with the base of the inner cylinder.  This was 
achieved using a modified Petri dish with a raised center region that contacted the 
membrane and supported the weight of the device.  Once the stretch chamber was moved 
to the microscope stage and connected to a syringe pump, applying pressure equal to 0.2 
psi below ambient conditions served to create the seal between the membrane and the 
chamber without imposing strain on the substrate.  The device could then be moved out 






2.2.4 Patterned mPAD Functionalization 
mPAD surfaces were selectively patterned to promote the adhesion of cultured 
cells in a pair configuration for cell-cell interaction studies (Figure 2.7 B).  Controlled 
regions of fibronectin were applied to the mPAD surface using the aforementioned 
stamping technique in conjunction with patterned PDMS stamps (Figure 2.7 B).  
Patterned PDMS stamps were molded from SU-8 (Micro Chem, Newton MA) masters 
that were pattered using standard photolithography techniques.  Briefly, a standard silicon 
wafer was spin coated with SU-8 10 at 2000 rpm for 30s, pre-baked @ 65C for 2 minutes 
followed by a soft-bake @ 95C for 5 minutes.  The substrates were then exposed for 5s to 
obtain ~100-150 J/m
2
 , and then post exposure baked for 1 minute @ 65C and 2 minutes 




















Figure 2.7: (A) Schematic of stamping technique used on mPADS (top), and a phase 
contrast image showing the surface of a bow-tie patterned PDMS stamp (bottom). (B)  
Phase contrast image of a BPASMC cell pair adhered to patterned micropost array.  






2.3 Experimental Techniques 
2.3.1 Cell Culture on Microposts 
Cells in suspension seeded onto functionalized micropost arrays will attach and 
spread across the micropost tops (Figure 2.4).  For experiments requiring fully spread 
cells, substrates were incubated overnight (10-12 hours) following seeding.  To obtain 
isolated cells surrounded by a sufficient number of empty posts as required for analysis 
(Section 2.3.2), 50 µl drops of suspended cells at an approximate concentration of 10,000 
cells/ml were applied to a micropost substrate submerged in 3-4ml of media, and the 
density above the array was checked via microscopy prior to incubation.  Experiments 
measuring cellular traction forces were conducted on a Nikon Eclipse TE-2000 
microscope with epi-fluorescence attachment, and images were acquired using a 
Photometrics CoolSnap HQ CCD camera.  Micropost substrates were placed into glass 
bottom culture dishes before transfer to the microscope stage.  A small amount of 
vacuum grease (Corning), sterilized by autoclaving, was used to keep the micropost 
substrate secure and immobile in the culture dish during imaging.  Experiments not 
involving external connections or stage mounted devices were performed using a custom 
built stage mounted chamber and live cell incubation system (LiveCell, Westminster 
MD).  This system enclosed the microscope stage in order to regulate and maintain 
culture conditions of 37C and either 5% or 10% CO2, depending on cell type.  Single 
cells were located on the array using phase contrast microscopy and a 10x objective, 
followed by imaging of both the cell and the underlying post array at either 40x or 60x 
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using either phase contrast (Figure 2.8 B), fluorescence (Figure 2.8 A), or bright field 




Figure 2.8: Fluorescence (A), phase contrast (B), and bright field (C) images of single 
cells adhered to mPADs. The bright field image was then inverted (D) to obtain light 






The most robust method for imaging the post array was to use bright field 
microscopy, without any phase contrast, in conjunction with pre-processing prior to 
analysis.  This was achieved on our microscope by using the “M” setting at the front 
focal plane of the microscope’s condenser.  This particular setting is meant for use with 
DIC microscopy, and therefore does not contain a phase ring.  Using this method, 
resulted in an image where individual microposts were dark on a light background 
(Figure 2.8 C).  This method resulted in images with very low background and the least 
amount of distortion caused by thick regions of cell body, as well as removing the need 
for fluorescently labeled posts.  Prior to analysis, these images required inversion of data 
values so that posts appeared light on a dark background (Figure 2.8 D).  All post array 
images of any type undergo “rolling ball” background removal prior to analysis     
(Figure 2.9).  This background subtraction algorithm uses a sliding paraboloid with a 
user-defined radius of curvature to remove unwanted background signal.  This process 
can be thought of as a ball rolling on the underside of a pixel intensity plot, resulting in 
all pixels coming in contact with the ball’s surface having their intensity value set to 0.  
Therefore, the ball’s radius was defined such that the objects of interest, in this case, 
microposts, are smaller than the selected radius.  This way, the ball does not “fall in” to 
the intensity peaks, and instead removes all background noise that exists in between 






Figure 2.9: Inverted bright field images showing an mPAD before (A) and after (B) 
rolling ball background removal. 
 
 
2.3.2 Micropost Image Analysis and Data Reduction 
 Micropost array images were analyzed and cellular traction forces calculated 
using custom software written in Igor Pro (Wavemetrics) (Figure 2.10).  The analysis 
began with numerical indexing of all posts in a selected region of interest (ROI) that 
contained the posts to which a cell was adhered, as well as a large number of empty posts 






Figure 2.10: Phase contrast image of BPASMC adhered to a micropost array with 
calculated force vectors present for each post in contact with the cell. 
 
 
Following ROI selection, the center location of each post was determined via two 
dimensional Gaussian fitting (Figure 2.11 B, C) [25].  Posts to which a cell was adhered 
were deflected by the cell’s contractile forces (Figure 2.11 E).  These deflections were 
measured relative to each cell post’s un-deflected position.  Un-deflected positions were 
interpolated from the intersections of best fit lines determined by the positions of all 
empty posts (Figure 2.11 F) surrounding, but not in contact with, the cell.  Once all cell 
post deflections were measured, the force acting on each individual post was calculated 
and a vector map for the entire cell was then overlaid on the post array images (Figure 
2.10).  Forces are calculated by treating each post as a simple spring, F = -kx.  Here k is 
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the “spring constant” for small deflections as determined by bending of individual posts 
using calibrated glass micropipettes moved by a piezoelectric controller [21].  For all of 
the mPAD experiments in this work, the microposts used were 5.7μm tall, 1.8μm in 
diameter with a 4μm post-to-post spacing, and had a spring constant of 22nN/μm.  For a 
whole cell scalar measure of cellular contractility, the measured post deflections were 
used to calculate the strain energy stored in each deflected post, which were then summed 
over all posts that the cell was adhered to,   
 
 
   
 
 .  These procedures were 
performed for each post array image, and the software had the capability of analyzing a 













Figure 2.11: Analyzed fluorescence image showing force vector map of adherent cell (A).  
Below are magnified images of a cell-attached (B) and empty (C) micropost, and cuts in 
the x-direction and y-direction with the associated Gaussian fits. Time traces of each 
post’s center location over the course of an experiment for the cell-attached (E) and 
empty (F) posts.  Note the y-axis scaling on these plots, where (F) shows the noise level 
for the background post, and (E) shows true deflections due to application of force. 
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2.3.3 Measurement of Cell-Cell Force 
 
Figure 2.12: Schematic diagram of a cell pair adhered to an mPAD (ref Liu).  Force 
vectors indicate cell-substrate forces for each cell, as well as the cell-cell force acting 
between the cells.   
 
 Cells remained stationary when adhered to the post arrays over short time scales, 
and therefore must have experienced a net force of zero across the cell body.  For cells 
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 , cell-substrate forces measured via mPADs enabled 















Chapter 3 Cardiac Fibroblast 
Contractility 
3.1 Introduction 
 This chapter describes experiments using mPADs to measure the mechanical 
output of cardiac fibroblasts.  The goal of these studies was to elucidate the role of 
fibroblast contractility in mechanical coupling of cardiac fibroblasts and cardiac 
myocytes.  While completed as part of a cell-cell interaction study through collaboration 
with the lab of Leslie Tung in the Johns Hopkins University Department of Biomedical 
Engineering, taken alone, the following measurements provide a comprehensive 
characterization of the mechanical properties of neonatal rat ventricular fibroblasts 
(cardiac fibroblasts) using mPADs.  These results are described in two publications     
[27, 28].   
Experiments conducted in the lab of Leslie Tung used a cardiac tissue model 
consisting of a patterned cardiac myocyte monolayer supplemented with either cardiac 
fibroblasts (CFs) or cardiac myofibroblasts (CMFs) (Figure 3.1 A).  The purpose of this 
tissue model was to simulate cardiac muscle tissue that naturally contains both myocytes 
and fibrobloasts/myofibroblasts.  Myocyte beating was induced through application of an 
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electrical signal, and a voltage sensitive dye was used to measure the velocity with which 
the applied electrical signal propagated through the model tissue. These experiments 
showed significant slowing of conduction velocity between control monolayers 
supplemented with CFs and tissues supplemented with CMFs (Figure 3.1 B), which 
simulate fibrotic tissue [27]. These changes were hypothesized to be a result of 
mechanical coupling between the myocytes and the CF’s/CMF’s, through which CMF 
contractile forces act on and open stretch activated ion channels located within the 
myocyte membrane.  In order to investigate this hypothesis, conduction velocity in model 
tissues was measured under various experimental conditions that altered either CMF 
contractility, or aspects of the proposed coupling mechanisms between the CMFs and 
cardiac myocytes.  The experiments described here measuring CMF force generation on 
mPADs provided a direct measurement and characterization of CMF mechanical output 

















Figure 3.1: (A) Fluorescence images of control and fibrotic model cardiac tissues.  α-
actinin in red denotes cardiac myocytes, α-SMA in green denotes CMFs, and all cell 
nuclei are shown in blue.  Nuclei not associated with a cell positive for α-actinin or α-
SMA denotes a control CF.  (B) Plot of conduction velocity shows significant slowing in 
tissues supplemented with CMFs (fibrotic) as compared with tissues supplemented with 














3.2.1 Short Duration Treatments 
 The effects of various drug treatments on cellular contractility were observed by 
imaging cells in normal conditions, followed by incubation with drug containing media, 
and then imaging of the same cells following treatment.  Because the micropost 
substrates were moved into an incubator for the treatment step, care was taken to allow 
for accurate identification of cells that were originally imaged.  Depending on the length 
of treatment time, cells may have changed shape or migrated on the post substrate.  
Therefore, during the initial imaging procedure, cell locations, morphologies, and 
substrate orientation were carefully documented in order to ensure imaging of the same 
set of cells after treatment.  Once imaging was completed, the images of each cell were 
then analyzed to determine changes in cellular contractility. 
3.2.2 Long Duration Treatments 
Cell treatments requiring incubation time greater than two hours greatly reduced 
the feasibility of tracking changes in contractility for specific individual cells.  The 
translational and morphological changes that cells exhibited over multiple hour treatment 
times made re-location of specific cells following treatment impractical.  In these cases, 
cells were treated prior to seeding on mPADs, and average total strain energy per cell was 
compared with that of a control group from the same culture that was not treated prior to 




3.2.3 Traction Force Dynamics During Cell Spreading  
 In order to observe traction force dynamics during cell attachment and spreading, 
cells were seeded onto mPADs and imaged without prior incubation.  In contrast to the 
standard stamping procedure outlined previously (Section 2.2.1), which only deposited 
ECM onto the post tops, micropost arrays were immersed in 50ug/ml fibronectin solution 
for 1 hour, which resulted in a fully ECM-coated substrate.  Because not all cells 
contacting the array would successfully spread, and given the need for real time 
measurement during the process, this method was chosen because it increased the 
probability of observing a cell that would successfully spread.  To further increase this 
probability, cells showing early process development were chosen for imaging 10 
minutes after seeding.  Images were taken once every minute using a Nikon TE2000 
microscope and a 60x objective.  The thickness of a cell in the process of spreading 
caused a distorted view of the post tops when viewed using phase contrast imaging.  For 
this experiment mPADs were stained using Rhodamine B, or bright field imaging with 
post-processing (Section 2.3.1).  Cell spreading area was also tracked using phase 










 In vivo, fibroblast differentiation into the more contractile myofibroblast 
phenotype is facilitated by the release of transforming growth factor beta (TGF-β) [20] .  
This transformation was facilitated in vitro through supplementation of culture media 
with 5ng/ml TGF-β for 48-72 hours prior to seeding on mPADs.   Cardiac fibroblasts that 
have been treated with TGF-β will be referred to as CMFs throughout this work.  In order 
to directly measure the effect of TGF-β treatment on fibroblast contractility in vitro, 
CMFs were cultured on mPADs, imaged, and their contractile forces measured.  Whole 
cell strain energy (   
 
 
   
 
   was averaged for all cells of a TGF-β treated CMF 
population for comparison with the average strain energy of a population of control CF’s 
from the same culture that were not exposed to TGF-β.  Control CFs exhibited a wide 
range of strain energies imparted to the mPAD, a representative sample of which is 
shown in Figure 3.2.  While the TGF-β treated population also showed a wide range of 
contractility        (Figure 3.3), treatment resulted in a 50% increase in average CMF 
contractile energy imparted to the elastic micropost arrays (E=183 ±12fJ [n=100]) as 

















































































































































































































The large range of contractile energies observed caused considerable overlap in 
the whole cell strain energy distributions between the two populations.  A cumulative 
energy distribution serves to clearly convey the difference in contractile output between 
the cells in these two populations (Figure 3.4).  This distribution shows the probability (y-
axis) that a cell in a given population will have a whole cell contractile energy greater 
than or equal to a given energy value (x-axis).  The vertical separation between the 
control and TGF-β traces shows a greater probability of finding more contractile cells in 
the TGF-β treated population. 
 
 
Figure 3.4: Cumulative distribution shows the probability (y-axis) that a cell in a given 
population will have a whole cell contractile energy greater than or equal to a selected 
value (x-axis).  The vertical separation between the control and TGF-β traces shows 




3.2.2 Blebbistatin  
 As mentioned previously, cells generate contractile forces primarily through the 
action of myosin motors within the actin cytoskeleton (Section 1.1.2).  The drug 
blebbistatin inhibits myosin II activity by blocking the myosin head with a complex that 
has low affinity for actin [29], thus reducing a cell’s ability to generate contractile forces.  
 
 
Figure 3.5: Graphical schematic of the hypothesized result of CMF contraction inhibition 
on fibrotic tissue conduction velocity (CV). 
 
To elucidate the role of CF contractility within the mechanical coupling 
hypothesis, blebbistatin was added to culture media in order to reduce myofibroblast 
contractility.  If the observed conduction slowing was a result of the action of 
myofibroblast contractile forces acting on the myocytes, blebbistatin treatment would 
serve to increase conduction velocity in fibrotic model tissues (Figure 3.5).  Experiments 
conducted in the Tung lab using model tissues supplemented with blebbistatin-treated 
CMFs found a significant increase in conduction velocity as compared to tissues 
supplemented with untreated CMF’s (Figure 3.6).  Quantification of the effects of 
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blebbistatin treatment on the contractility of CMFs was performed through direct 




Figure 3.6: Comparison of conduction velocity on fibrotic model tissues containing 
CMFs before and after treatment (n=5).  Dashed lines indicate individual model tissues, 
and connect measurements before and after Blebbistatin treatment.  30 minute treatment 
with Blebbistatin resulted in an increase in conduction velocity, a reversal of the effects 











CMFs cultured on mPADs were imaged before and after treatment with 100 μM 
Blebbistatin for 30 minutes.  Representative data for four CMF cells are shown in Figures 
3.7 and 3.8.  The uniform reduction in cell-substrate contractile forces following 




Figure 3.7: Force vector plots of two CMFs before and after Blebbistatin treatment 
showing reduction in contractile forces.  Inset is whole cell strain energy.  Scale vector is 
10 nN. 
  







Figure 3.8: Force vector plots of two CMFs before and after Blebbistatin treatment 





           Before                          After 
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The result of Blebbistatin treatment for all cells measured, quantified through the 
change in strain energy, is shown in Figure 3.9.  Each cell showed a significant drop in 
strain energy.  Overall, there was an average reduction in strain energy of 74.5%, from     
E = 278 ± 38fJ to E = 71 ± 14fJ (n=9) (Figure 3.9).  
 
 
Figure 3.9: Change in total cell strain energy for CMFs (n = 9) using mPADs.  
Blebbistatin treatment results in a 74.5% reduction in contractile output.  (From [27]) 
 
3.3.3 Mechanosensitive Channel Blockers (Gadolinium, Streptomycin) 
Mechano-sensitive channels (MSCs) are transmembrane ion channels that open or 
are otherwise altered as a result of mechanical stimulus, allowing for passage of ions 
between the cytoplasm and the extracellular space.  MSC function can be inhibited in the 
presence of certain MSC blockers, such as gadolinium and streptomycin, as used in this 
study.  For example, gadolinium ions have been shown to block MSCs through 
mechanisms that limit the channel open time, reduce the current through open channels, 




Figure 3.10:Graphical schematic of the hypothesized result of blocking mechano-




These treatments served to determine the effect of inhibiting the action of CMF 
contractile forces acting on the cardiac myocytes, without interfering with CMF force 
generation (Figure 3.10). MSC blocker treatment on cardiac tissues resulted in an 
increase in conduction velocity, consistent with inhibition of MSC-mediated CV slowing 




Figure 3.11: Changes in conduction velocity on fibrotic model tissues containing CMFs.  
Supplementation with gadolinium (n=5) and streptomycin (n=4) resulted in an increase in 
conduction velocity, a reversal of the effects of CMF supplementation. (From [27]) (Data 
courtesy of Susan Thompson) 
 
 
In conjunction with conduction velocity experiments, mPAD experiments were 
used to measure MSC blocker effects on CMF contractility.  Changes in total cell strain 
energy for 10 CMFs before and after treatment with 50μM gadolinium for 30 minutes 
resulted in no significant effect on CMF contractility. Four cells from this experiment are 
shown in Figures 3.12 and 3.13; none showed changes outside the normal range of 
fluctuations in contractile forces or strain energy over such an interval.  Treatment with 
streptomycin under the same protocol yielded similar results, as illustrated for four 
representative cells in Figures 3.14 and 3.15.  The results for the changes in strain energy 
for all cells measured in both conditions are shown in Figure. 3.16. For the gadolinium-




and  E = 225 ± 31fJ (after treatment) [N=10]. For the streptomycin-treated group, we 
found E = 310 ± 41 fJ  (before treatment), and E = 310 ± 38 fJ  (after treatment) [N = 9].   
Averaging the two groups together yielded E = 264 ± 26 fJ  (before treatment), and E = 




Figure 3.12: Force vector plots of CMFs before and after gadolinium treatment. No 
reduction in contractility was observed.  Inset is whole cell strain energy.  Scale vector is 
10 nN. 
 







Figure 3.13: Force vector plots of CMFs before and after gadolinium treatment. No 










Figure 3.14: Force vector plots of CMFs before and after streptomycin treatment. No 
reduction in contractility was observed.  Inset is whole cell strain energy.  Scale vector is 
10 nN. 
 






Figure 3.15: Force vector plots of CMFs before and after streptomycin treatment.  No 
reduction in contractility was observed.  Inset is whole cell strain energy.  Scale vector is 
10 nN. 
 




Figure 3.16: Comparison of CMF whole cell strain energy measured using mPADs.  
Treatment with gadolinium (red) or streptomycin (blue) had no significant affect on CMF 
contractility. (From [27]) 
 
3.3.4 Gap Junction Knockdowns 
 Gap junctions are specialized connections between adjacent cells that allow for 
the passage of various molecules and ions.  The primary gap junction protein associated 
with electrical coupling in cardiac tissue is connexin 43 [31].  In order to clearly observe 
the contribution to conduction slowing from electrical cell-cell interactions between 
cardiac fibroblasts and cardiac myocytes, shRNA transduction was used to inhibit the 
cells’ ability to produce connexin 43, a technique known as “silencing”, in a population 
of CMFs prior to seeding on myocyte monolayers.  The effects of shRNA transduction 
were controlled for by an identical treatment using scrambled shRNA, which had no 
effect on the cell’s ability to express connexin 43.  Experiments performed in the Tung 
lab showed that silencing connexin 43 expression did not suppress the conduction 
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slowing observed in fibrotic tissues.  These results suggest that electrical coupling is not 
the primary mechanism behind the conduction slowing we observed in model cardiac 
tissues [27].   
The effect of connexin 43 silencing on CF contractility was measured using 
mPADs.  As before, when measuring separate populations of CMFs, a large spread in cell 
strain energy was observed.  Figures 3.17 and 3.18 show representative force vector maps 
spanning a wide range of energies for control and silenced CMFs, respectively.  Figure 
3.19 is a cumulative distribution of whole cell strain energies for each population.  The 
trace overlap shows that the probability of finding a cell with any given value of strain 
energy is comparable for the two populations.  Average strain energies for the two 
populations were not significantly different (p = 0.5): 




























































































































































































































































Figure 3.18: Cumulative distribution shows the probability (y-axis) that a cell in a given 
population will have a whole cell contractile energy greater than or equal to a selected 
value (x-axis).  The lack of vertical separation between the control and connexin 43 
shRNA traces shows no affect on contractility due to treatment. (From [27]) 
 
3.3.5 Adherens Junction Knockdowns 
Mechanical linkages known as adherens junctions (Section 1.2.2) serve to 
mechanically link the cytoskeletons of adjacent cells.  These junctions include 
transmembrane cadherin proteins, the external portion of which serves as binding points 
between cells. The internally exposed regions of cadherins are bound by other proteins 
(catenin, vinculin) to actin fibers that make up the cytoskeleton.  Binding to actin allows 
adherens junctions to serve as points of force transfer between coupled cells [32, 33].  To 
investigate mechanical coupling via adherens junctions between cardiac myofibroblasts 
and myocytes, populations of CMF’s were silenced for specific types of cadherins known 
to abundant in heart tissue [25, 34-36] in order to disrupt mechanical coupling.  
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Subsequent measurements of model tissue conduction velocity were combined with 
measurements of CMF contractility on mPADs to further characterize CMF myocyte 
mechanical coupling, and to determine the affects of cadherin silencing on CMF force 
generation.  Figures 3.19 and 3.20 show force vector maps of representative cells from 
both control (top row) and silenced (bottom row) populations for OB-cadherin and        
N-cadherin knockdowns, respectively, illustrating the spread observed in the contractility 
of both cell populations.  Silencing of both OB-cadherin and N-cadherin had no 
significant effect on CMF contractility compared to control cells (Figure 3.21).  
However, while silencing of OB-cadherin had no significant effect on model tissue 
conduction velocity (Figure 3.22), silencing of N-cadherin served to restore conduction 









































































































































































































































































































































































Figure 3.21: Experiments using mPADs show no affect on CMF contractility due to 
silencing of either OB-Cadherin or N-Cadherin. (From [28]) 
 
Figure 3.22: Conduction velocity experiments found no affect on conduction slowing due 
to OB-Cadherin silencing, but significant restoration of conduction velocity due to N-




3.3.5 Modulation of RhoA activity 
 RhoA is a small GTPase protein known to regulate acto-myosin force generation 
(Section 1.1.2)  through activation of ROCK, which in turn phosphorylates, or activates, 
myosin light chain (MLC) and MLC phosphatase, both of which contribute to 
contractility [2].  Micropost arrays were used to measure the contractile output of CMFs 
treated by viral intervention to express dominant negative (N19) and constitutively active 
(V14) forms of RhoA.  The same cell populations were used for supplementation on 
model cardiac tissues to determine the effects of altered CMF contraction on conduction 
velocity.  Figure 3.23 shows representative force vector maps for N19-expressing (top 
row) and V14-expressing (bottom row) CMFs.  Measurements using mPADs found a 
significant difference in contraction between the two treatments:  E = 126 ± 20 fJ, (n = 
15)(N19) and E = 247 ± 28 fJ, (n = 15)(V14) (Figure 3.24).  While supplementation of 
V14-expressing CMFs onto model cardiac tissues resulted in conduction slowing levels 
similar to CMFs expressing GFP and wild type RhoA (Figure 3.25 B), reduced 
conduction slowing was observed for tissues supplemented with N19-expressing CMFs 












































































































































Figure 3.24: Experiments on mPADs found a significant increase in CMF force 
generation as a result of Rho-V14 expression, and a significant decrease due to 
expression of Rho-N19. (From [28]) 
 
 
Figure 3.25: Results of conduction velocity experiments show significantly restored CV 
due to expression of dominant negative Rho-N19 (A).  Rho-V14 expressing CMFs do not 





Y-27632 is a drug that selectively inhibits p160ROCK, a protein known to 
regulate focal adhesion and stress fiber assembly, as well as force generation, through 
phosphorylation of myosin light chain (MLC).  Micropost arrays were used to measure 
the affect of Y-27632 treatment on cardiac myofibroblast contractility.  Single CMFs 
adhered to mPADs were imaged before and after treatment with 50μM Y-27632 (Sigma) 

















Figure 3.26: Force vector plots of CMFs before and after Y-27632 treatment.  Inset is 









Figure 3.27: Force vector plots of CMFs before and after Y-27632 treatment.  Inset is 
whole cell strain energy.  Scale vector is 10 nN.  
 
 
           Before                       After 
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Treatment resulted in a dramatic decrease in average total cell strain energy:                         
E = 226 ± 30 fJ (before), E = 15 ± 3 fJ (after), n=9 (Figure 3.28). 
  
 
Figure 3.28: Change in total cell strain energy for n = 9 CMFs as a result of treatment 
with Y-27632. 
 
3.3.6 Cardiac Myofibroblast Force Generation During Cell Spreading  
 Observation of CMFs immediately following seeding onto micropost arrays 
allowed for measurement of contractile force dynamics during the spreading process.  
These measurements investigated the role of CMF contractility in conduction velocity 
slowing of model tissues that was observed within 30 minutes of supplementation with 
CMFs.  For 12 cells observed, the onset of visible micropost deflection occurred after an 
average of 32 minutes following seeding onto mPADs.   Cells generally showed low 
magnitude forces when actively increasing their area (Figure 3.29 A-D), followed by 
rapid initiation of force generation when approaching maximum area (Figure 3.29 E).  
Forces continued to increase after stabilization of cell area (Figure 3.29 F-H).  Figures 
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3.30 and 3.31 show force vector maps for two different CMFs at elected time points 
beginning 10-15 minutes after CMF seeding on an mPADs, as well as the evolution of 
total cell strain energy and cell area over time. Experiments on model cardiac tissues 
were also performed immediately following CMF supplementation and the effects on 
conduction velocity were measured, finding that the onset of conduction slowing could 
occur as early as 20 minutes, consistent with the time course of CMF force generation 
observed on mPADs.  Taken together, these results further demonstrate the effects of 


















































































































































































































Figure 3.30: Top: Force vector maps of a CMF shortly after seeding on an mPAD.  Insets 
show time since seeding and whole cell strain energy.  Scale vector is 10 nN.  Bottom: 





Figure 3.31: Top: Force vector maps of a CMF shortly after seeding on an mPAD.  Insets 
show time since seeding and whole cell strain energy.  Scale vector is 10 nN.  Bottom: 






 This work has provided, for the first time, characterization of neonatal rat 
ventricular fibroblast contractility using mPADs.  Basal contractile capabilities, as 
determined by the total bending energy imparted to a flexible micropost substrate by a 
single CF, were measured for a large number of cells from multiple cultures.  These 
measurements provided a direct quantitative measure of CF contractile output.  Changes 
in fibroblast contractility were measured in response to a multitude of treatments chosen 
to elucidate the nature and effects of mechanical heterocellular coupling between CFs and 
neonatal rat ventricular myocytes (NRVMs).  Experiments measuring the velocity of 
electrical signal propagation, or conduction velocity (CV), in model cardiac tissues 
consisting of patterned monolayers of cardiac myocytes revealed significant CV slowing 
when the monolayers were supplemented with CFs.  CV slowing was exacerbated when 
the monolayers were supplemented with CMFs, a more contractile CF phenotype brought 
on by treatment with transforming growth factor beta (TGF-β).  These changes were 
hypothesized to be a result of mechanical coupling between the myocytes and the 
CFs/CMFs, through which CF/CMF contractile forces act on and open stretch activated 
ion channels located within the myocyte membrane.  CF and CMF contraction were 
measured using mPADs, showing CMFs to be capable of generating significantly 
increased contractile forces compared to CFs.  These results were consistent with 
previous studies by Lijnen et al. that utilized gel contraction assays [37].  Further 
experiments were performed in order to modulate CMF contraction and observe the 
resulting affect on CV in CMF supplemented myocyte monolayers.  CMF treatment with 
the acto-myosin inhibitor blebbistatin was found to significantly decrease CMF 
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contractility.  Treatment of CMFs with blebbistatin prior to seeding on myocytes 
monolayers was shown to reverse the conduction slowing effects previously observed as 
a result of CMF supplementation, highlighting the importance of CMF contractility in the 
observed CV slowing resulting from interactions between these two cell types.  Further 
regulation of CMF contractility was achieved through genetic modification to modulate 
RhoA activity via expression of either constitutively active Rho-V14, which resulted in 
increased CMF contractile force generation, or expression of dominant negative Rho-
N19, which resulted in a significant decrease in CMF contractile force generation.  When 
the genetically modified CMFs were used for supplementation onto myocyte monolayers, 
monolayers containing the less contractile Rho-N19 expressing CMFs were found to 
have improved CV as compared to those with unmodified CMFs, and the more 
contractile Rho-V14 expressing CMFs did not further reduce CV as compared to 
monolayers supplemented with unmodified CMFs.  These results demonstrated that CV 
slowing in model cardiac tissues as a result of the action of CMF contractile force 
generation is likely saturated by the levels of force generated by unmodified CMFs, and 
is not bolstered by further increases in CMF contractility.  However, CV could be 
significantly reduced by reducing CMF contractility.  Furthermore, it was observed that 
the onset of CV slowing in CMF supplemented myocyte monolayers could occur as early 
as 30 minutes following CMF supplementation, and measurement of CMF contractile 
force dynamics during cell spreading found that the onset of significant traction, on 
average, also occurred at ~30 minutes.  Contractile forces continued to increase after 
stabilization of cell area, similar to observations made by Thaler et al using mouse 
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embryonic fibroblasts [38].  The above experiments demonstrate the significance of CMF 
contractility in driving CV slowing in model cardiac tissue. 
To investigate mechanisms through which CMF force generation could be 
affecting myocyte function, chemical and genetic treatments that did not interfere       
with CMF contractility were performed.  Treatment with the mechanosensistive channel 
(MSC) blockers gadolinium and streptomycin had no significant affect on CMF 
contractility, yet CV was significantly restored in CMF supplemented myocyte 
monolayers treated with either gadolinium or streptomycin.  These results make clear that 
a significant element of the coupling responsible for CV slowing is the activation of 
MSCs resident in the myocyte membranes.  The role of cell-cell adhesions was directly 
explored using genetic “silencing” techniques used to inhibit the cells’ ability to express 
junctional proteins associated with both electrical and mechanical cell-cell coupling.  
Inhibiting expression of the gap junction protein connexin 43 in CMFs had no significant 
effect on either CV in monolayer experiments, or CMF contractility, demonstrating that 
electrical coupling via connexin 43 is not responsible for the observed effects.  In 
contrast, while inhibited expression of two cadherin proteins associated with mechanical 
cell-cell coupling (N-cadherin, OB-cadherin) was found to have no significant affect on 
CMF force generation, silencing of N-cadherin served to alleviate the CV slowing effects 
in CMF supplemented monolayers.  These results define mechanical coupling via N-
cadherin as an important element contributing to CMF-myocyte coupling.     
Taken together, the results of CV experiments performed in the Tung lab using 
CMF supplemented model cardiac tissues, combined with the direct measurements of 
CMF contractile forces using mPADs described here, have identified a potential 
80 
 
mechanism by which injury-induced transformation of CFs into highly contractile CMFs 



















Chapter 4 Cellular Traction Force 
Response to Global Stretch 
4.1 Introduction 
The following experiments utilized a modified version of the micropost array 
detector (mPAD) that allowed for real time measurement of cell generated traction forces 
in response to global stretch stimulation.  Cellular response to short duration 5s stretches 
was quantified through changes in whole cell strain energy imparted to the mPAD 
substrate following transient stretch.  Longer stretches ~ 4 minutes in duration were 
applied and the cellular response was measured during the application of stretch.    
The arterial smooth muscle cells and surrounding extra cellular matrix that 
comprise the inner walls of blood vessels are routinely exposed to external global 
stretching forces caused by changes in blood pressure.  In order to establish a more 
complete understanding of blood vessel physiology, it is therefore necessary to 
understand how the cells and tissue that form blood vessels respond and adapt in such a 
mechanically dynamic environment.  To this end, I have developed an experimental 
procedure using the mPAD device described previously, which enabled the measurement 
of cell generated traction force dynamics during an applied stretch. 
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4.2 Experimental Techniques 
4.2.2 Transient 5s Stretch 
 Biaxial strains in the range up to 20% were applied with the custom-built 
vacuum-controlled stretching device described in Section 2.2.3.  Prior to application of 
stretch, single cells were imaged using a 40x or a 60x microscope objective in order to 
establish their baseline contractile forces.  Following baseline imaging, cells were 
observed using a 10x objective to ensure an accurate visual account of cell morphology 
and location in order to re-locate the cell following transient stretch.  Stretch was applied 
by manual syringe pump operation to bring the system to the vacuum pressure 
corresponding to the desired level of stretch.   Once maximum vacuum was reached, the 
stretch direction was reversed, bringing the system back to 0 psi.  For stretches of 7%-
10% strain, a maximum vacuum of -3.0 psi was used, and for stretches of 15-20% strain, 
a maximum vacuum of -4.0 psi was used.  Manual syringe pump operation resulted in 
transient stretches of approximately 5s duration.  Once stretch was completed, the cell of 
interest was re-located using the 10x objective.  Cell positions did not change 
substantially following stretch.  Once the substrate reached static equilibrium, 
observation using a 40x or a 60x objective resumed.  Following stretch, cells were 
imaged for 5 minutes, with a minimum of 15 minutes in between stretches applied to the 
same substrate.  The time period between stretches was chosen in order to allow all cells 
adhered to the substrate to reach a new quasi-static equilibrium state prior to being 
exposed to continued stretch application, consistent with recovery periods observed in 
human airway smooth muscle cells [39], and human bladder smooth muscle cells [40]. 
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4.2.3 Observation During Stretch Application 
 In order to observe dynamics of cellular traction forces during an applied stretch, 
images were taken while the substrate strain was actively changing, as opposed to before 
and after stretch application.  In this mode, observation using a 40x or a 60x objective, as 
needed to measure the microposts’ deflections with sufficient accuracy, required constant 
input from the user.  As the cells being observed were in general not in the center of the 
substrate, they translated in the x-y plane as the substrate stretched, requiring monitoring 
and adjustment of the stage position at all times in order to keep the cell of interest within 
view of the camera.  Along with changes in x-y position, imposition of substrate strain 
also caused changes in z positioning as the tension on the substrate membrane increased, 
requiring constant focus adjustment during the experiment.  These requirements were met 
by using two output ports on the microscope simultaneously; one port directing light to 
the camera for imaging, and another port directing light to the microscope eyepiece for 
real time observation.  While observing the sample through the eyepiece, the user could 
use one hand to maintain stage position while using the other hand to maintain focus on 








 for these 
experiments were achieved using a 60 ml syringe with the syringe pump set at 420 µl/min 
and the syringe diameter setting equal to 14.43 mm. These strain rates resulted in 
transient stretches of approximately 4 minute duration. 
4.2.4 Analysis 
 The inherent difficulties associated with micron scale imaging of a substrate in 
constant motion made the analysis for these experiments more challenging than the 
analysis performed on static substrates.  Data sets for time lapse evolution of cellular 
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traction forces typically consist of a stack of many images that can be analyzed 
sequentially with minimal initial input from the user.  This was not possible for 
experiments where observation took place during an applied stretch.  First, the subset of 
posts surrounding and including the cell must be present in every image in order to 
maintain a consistent region of interest where every post is uniquely identified and 
tracked.  Due to the large amount of lateral movement during applied stretch, on the order 
of 100’s of microns, as well as increasing strain causing fewer posts to be visible in later 
images, it was impossible to ensure that the same subset of posts would be present in 
every image.  Because of this, each image had to be analyzed separately using a unique 
ROI, greatly increasing the required user input.  Second, substrate movement in the z-
direction caused many of the acquired images to be out of focus.  In order to obtain 
analyzable data from these experiments, images that were properly focused had to be 
selected from the stack.  Care was taken to select a sufficient number and temporal 
spacing of images in order to have data that adequately displayed the cell’s response 
throughout the stretch.  Once images were selected, each one underwent pre-processing 
as described previously in section 2.3.1, followed by individual analysis.  Data from each 
individual analysis was then compiled from all analyzed images of a given cell, creating a 






4.3.1 Transient 5s Stretch 
As described previously (Section 2.3.2), for a whole-cell scalar measure of 
traction forces and cellular contractility, the strain energy stored in each micropost as a 
result of forces imparted by the cell was summed for every post to which the cell was 
adhered:    
 
 
   
 
 .  Following application of transient stretch, BPASMCs exhibit a 
dramatic decrease in traction forces (Figure 4.1 A, C).  Measures of whole cell strain 
energy imparted to the mPAD substrate revealed an average decrease of 49.77% (n=13) 
following application of a 7-10% magnitude stretch lasting approximately 5 seconds.  
Following stretch, cellular traction forces begin to recover in magnitude over the course 
of minutes (Figure 4.1 A, D).  New quasi-equilibrium whole cell strain energy values 
were generally near levels observed prior to stretch application (Figure 4.1 A), with some 
















Figure 4.1: (A) Whole cell strain energy vs. time for a BPASMC exposed to a transient 
8% stretch of 5s duration. Vector maps of cellular traction forces prior to stretch 
application. (B), immediately following stretch (C), and 14 minutes after stimulation.  








Figure 4.2: Whole cell strain energy vs. time for a BPASMC exposed to a transient 8% 
stretch of 5s duration.  Variation in quasi-static equilibrium following recovery after 
stretch included cells that recovered to energy values less than (A), and greater than (B) 
baseline energy values. 
 
4.3.2 Observation During Stretch 
 Using the aforementioned acquisition methods, traction force dynamics 
for BPASMCs were observed during application of a much slower transient stretch.  
These measurements provided a direct real time measurement of cellular behavior as 
substrate strain was actively changing.  Figure 4.3A shows a schematic representation of 
substrate strain versus time for these experiments.  Force vector maps corresponding to 
the red dots on the schematic show the contractile response of a BPASMC exposed to 
this stretch protocol.  At maximum strain (Figure 4.3 C), traction force magnitudes are 
dramatically increased relative to pre-stretch (Figure 4.3 B).  Traction forces decrease 
significantly upon reversal of substrate strain direction (Figure 4.3 D), and continue to 
decrease until stretch cessation (Figure 4.3 E).  Worth noting, cell strain was 
indistinguishable from substrate strain, indicating that the cells were generally less stiff 




Figure 4.3: Schematic time course of applied strain for observation of traction force 
dynamic during stretch (A).  Representative force vector maps show traction forces prior 
to stretch onset (B), at maximum strain (C), shortly after reversal of strain direction (D), 
and after stretch completion (E). 
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Whole cell strain energy was measured in response to applied stretch for multiple 
cells over a range of maximum strain values (Figures 4.4, 4.5).   Cellular traction force 
response during increasing substrate strain varied considerably across the observed 
population.  The initial response, from 0-2% substrate strain, of all cells (N = 25) was an  
increase in strain energy imparted to the mPAD.  Energy increases ranged from 5% - 
40%.  At strain values greater than 2%, cell to cell traction force dynamics varied greatly.  
While the increasing strain energy response persisted for a fraction of the cells tested 
(Figure 4.4 A, B; Figure 4.5 A, D), many cells exhibited a “plastic limit”, after which 
contraction energy would remain constant, decrease, or a time and strain varying 
combination of both (Figure 4.4 C,D,E,F; 4.5 B, C, E, F) .  However, despite the varying 
responses to increasing strain, at the onset of decreasing substrate strain, cell tractions 
promptly decreased in all cases, falling below the values observed during increasing 
strain.  Cell traction energies continued to decrease until stretch cessation, resulting in a 
final energy below pre-stretch levels, consistent with measurements performed 











Figure 4.4: Total cell strain energy versus substrate strain for a representative sample of 
BPASMCs.  Maximum strain values for these cells were 7% - 11%.  Strain protocol was 








Figure 4.5: Total cell strain energy versus substrate strain for a representative sample of 







Figure 4.6: Relative strain energy vs. normalized substrate strain for multiple single 
SMCs shown in two groups with average strain values of 8.2% (A) and 16.7% (B).  All 
cells exhibit hysteresis, with considerable variability in traction force response during 







Figure 4.7: Relative cell strain energy vs. strain rate for all cells tested.  Energy values 
correspond to substrate stains of 7.5% ± 1% I order to include cells from all strain ranges 
tested. 
 
Figure 4.7 shows the relative change in cell strain energy @ 7.5% ± 1% strain vs. 
strain rate for 25 cells.  While a weak positive correlation exists between the relative 
change in cell strange energy and strain rate, plots of relative cell strain energy versus 
(scaled) substrate strain (Figure 4.6 A, B) reveal a heterogeneous response to increasing 
strain across our tested cell population.  13 out of 25 cells exhibited energy changes 
during increasing substrate strain that did not exceed 50% of baseline, and the remaining 
12 out of 25 cells exhibited a reinforcing response, with energy increases exceeding 50% 
prior to strain reversal.  Worth noting, 4 of the 12 reinforcing cells did show energy 
decreases during increasing substrate strain, but only after an initial increase of greater 
than 50% of baseline. 
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Consistent with the response to short duration stretches described in the last 
section, left at rest, cell traction forces slowly recovered over the course minutes, and 
again showed significant variability in quasi-equilibrium strain energy values following 
recovery.  This can be seen in Figures 4.8, 4.10, and 4.12 that show total cell strain 
energy vs. time (A) and total cell strain energy vs. strain (B) that include the recovery 
period following stretch cessation. 
A more detailed analysis of cellular traction force dynamics is shown below for 
three representative cells that span the range of observed responses.  Data for each cell is 
shown using a pair of figures.  In Figures 4.8, 4.10, and 4.12, total cell strain energy and 
substrate strain vs. time are shown in panel A, and cell strain energy vs. substrate strain is 
shown in panel B.  Force vector maps pertaining to data points indicated on the plots in A 
and B show the change in cellular traction forces during the course of stretch application 
(Figure 4.8 C-G; Figures 4.10 and 4.12, C-F).  The second figure for each cell      
(Figures 4.9, 4.11, and 4.13) contains information about the evolution of the spatial 
distribution of cell strain energy imparted to the mPAD.  Panel A in each of these figures 
contains traces of strain energy vs. time for each individual post to which the cell is 
adhered (cell posts).  The right column of panels is heat maps that allow for easy 
visualization of strain energy distribution across the cell.  The heat maps correspond to 
the same data points indicated by arrows on the plots of the previous figures, and are 
numerically labeled for the specific data point that they represent.  The remaining panels 
(Figure 4.9 B-E; Figures 4.11 and 4.13 B-D), are plots of strain energy in a given frame 
vs. strain energy in an earlier frame for each cell post, where the axis labels again 
correspond to the previously indicated data points also labeling the heat maps.  These 
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plots indicate how the energy stored in each cell post evolves from one point to the next 
in response to the applied stretch.  Individual posts that gain energy will lie above the y = 
x line (blue trace), while those that lose energy will be below the y=x line.    
This analysis revealed that the measured whole-cell responses, which varied 
significantly from cell to cell, were generally uniform across all high energy cell posts 
(Figures 4.9 A, 4.11 A, and 4.13 A), and that the changes were restricted to regions of 
strong force generation (Figures 4.9, 4.11, and 4.13, heat maps).  The remaining plots in 
Figures 4.9, 4.11, and 4.13 further demonstrate the uniformity of the changes in total cell 
strain energy that occurred between the selected time points, as the positions of nearly all 






Figure 4.8: (A) Plots of cell strain energy (red, left axis) and substrate strain (blue, right 
axis) vs. time.  (B) Cell strain energy vs. substrate strain. (C-G) Force vector maps for 
selected time points (numeric label) during stretch application.  Points of interest 




Figure 4.9: (A) Strain energy vs. time for each individual cell post. Right column: Energy 
distribution heat maps across the entire cell.  Each map corresponds to a selected time 
point during stretch application (numeric labels, see Figure 4.8). (B-E) Energy evolution 
between time points indicated on axes (also see corresponding heat maps).  y = x line 




Figure 4.10: (A) Plots of cell strain energy (red, left axis) and substrate strain (blue, right 
axis) vs. time.  (B) Cell strain energy vs. substrate strain. (C-F) Force vector maps for 
selected time points (numeric label) during stretch application.  Points of interest 







Figure 4.11: (A) Strain energy vs. time for each individual cell post. Right column: 
Energy distribution heat maps across the entire cell.  Each map corresponds to a selected 
time point during stretch application (numeric labels, see Figure 4.10). (B-D) Energy 
evolution between time points indicated on axes (also see corresponding heat maps).       




Figure 4.12: (A) Plots of cell strain energy (red, left axis) and substrate strain (blue, right 
axis) vs. time.  (B) Cell strain energy vs. substrate strain. (C-F) Force vector maps for 
selected time points (numeric label) during stretch application.  Points of interest 







Figure 4.13: (A) Strain energy vs. time for each individual cell post. Right column: 
Energy distribution heat maps across the entire cell.  Each map corresponds to a selected 
time point during stretch application (numeric labels, see Figure 4.12). (B-D) Energy 
evolution between time points indicated on axes (also see corresponding heat maps).       




In order to enhance the cells’ ability to actively generate force and observe the 
effect on the traction force response during applied stretch, cells were treated to express 
constitutively active RhoA via transfected with V14 adenovirus (Section 2.1.3).  When 
exposed to long duration stretches and imaged during the stretch process, the overall 
response of Rho-V14 expressing cells (Figures 4.14 A-D, 4.15 A-E) was not significantly 
different from either control cells or cells virally treated to express GFP (not shown).   
As mentioned previously, control cells imaged before and after exposure to a 7-
10% stretch of 5s duration showed an average whole cell strain energy drop of 49.77% 
(n=13).  The same stretching protocol performed on RhoV14 expressing cells showed an 
average drop of only 20.62% (n=12).  The recovery response following stretch cessation 
was not significantly different from controls for either the short duration (Figure 4.16) or 
the long duration stretches (Figures 4.15, 4.16).  While a difference in response was 
observed between RhoV14-expressing cells and controls cells exposed to short duration 
stretches, RhoV14 expression caused reduced spreading on mPADs, which may have 













Figure 4.14: Total cell strain energy vs. substrate strain for four Rho-V14 expressing 
BPASMCs observed during stretch application.  Overall responses are not significantly 











Figure 4.15: (A, C, E) Total cell strain energy (red, left axis), substrate strain (blue, right 
axis) vs. time, and strain energy vs. substrate strain (B, D, F) for three Rho-V14 









Figure 4.16: (A) Whole cell strain energy vs. time for a Rho-V14 expressing BPASMC 
exposed to a transient 8% stretch of 5s duration. Vector maps of cellular traction forces 
prior to stretch application. (B), immediately following stretch (C), and 14 minutes after 






4.3.4 Sustained Stretch 
To further examine the response of BPASMCs to stretch stimulus, our 
experimental setup was used to expose cells to a sustained stretch.  This was achieved by 
bringing the flexible mPAD substrate to the desired strain level and then holding the 
vacuum pressure constant over time (Figure 4.17).  The few cells tested in this way 
exhibited elastic energy increases during the onset of stretch, followed by decreasing 
energy prior to reaching maximum substrate strain.  While strain was held constant, each 
cell exhibited decaying strain energy imparted to the mPAD. 
 
Figure 4.17: Total cell strain energy (red, left axis) and substrate strain (blue, right axis) 




4.3.5 Cell Pairs 
Patterning techniques described previously were used to culture cells in pair 
configurations on flexible mPADs for stretch application (Figures 4.18 A, 4.19 A).  
Measurement of whole cell strain energy during stretch for each cell individual cell a pair 
shows a global response similar to that observed for single cells.  Worth noting is that the 
response of paired cells displays a degree of synchronization (Figures 4.18 B, 4.19 B).  
Determination of the force acting at cell-cell adhesions (cell-cell force, Section 2.3.3) 
shows that not only do cell-cell adhesions remain intact during stretch, but the response 
to stimulus of the force acting at these sites is modulated synchronously with cell-
substrate forces (Figures 4.18 C, 4.19 C).  Even though the cell-cell force for the pair in 
Figure 4.19 is relatively low magnitude, the response still captures the hysteresis 














Figure 4.18: (A) Phase contrast image of a cell pair adhered to an mPAD.  Cell one is 
outlined in red, cell two in blue.  Cell-substrate force vectors are shown in red and cell-
cell force vectors in white.  (B) Total cell strain energy vs. substrate strain for both cells.  
(C) Cell-cell force vs. substrate strain as calculated from unbalanced cell-substrate forces 










Figure 4.19: (A) Phase contrast image of a cell pair adhered to an mPAD.  Cell one is 
outlined in red, cell two in blue.  Cell-substrate force vectors are shown in red and cell-
cell force vectors in white.  (B) Total cell strain energy vs. substrate strain for both cells.  
(C) Cell-cell force vs. substrate strain as calculated from unbalanced cell-substrate forces 








Fast Stretch.  The traction force response of BPASMCs exposed to a short 
duration (5s) transient stretch of 10% magnitude is consistent with previous findings for 
human airway smooth muscle cells (HASMCs) [39] and human bladder smooth muscle 
cells (HBSMCs) [40].  Namely, a prompt decrease in traction forces immediately after 
stretch cessation, followed by slow recovery over the course of minutes.  The resulting 
quasi-static equilibrium values following recovery for HASM and HBSM cells were 
generally reported to be equal to pre-stretch values, or slightly below.  While our results 
showed that this was indeed the case for many of the BPASM cells tested, some cells 
reached new contractile energy values that were much greater than pre-stretch levels.  
Similar results for HASM and HBSM cells were found only after exposure to non-
homogeneous stretches, where the strain field varied continuously across the cell.. Our 
results show that while there may be two mechanisms responsible for the response to 
either homogeneous or non-homogenous stretch, some overlap exists allowing for 
BPASMCs to sometimes reinforce following homogeneous stretch.  The studies 
mentioned then explored the affect of transient stretch on the structural dynamics of 
cytoskeletal actin fibers.  Immunostaining for both the filamentous (f-actin) and globular 
(g-actin) forms of actin revealed that actin in cells exposed to transient stretch underwent 
rapid depolymerization following stretch, observed as a significant increase in the ratio of 
g-actin to f-actin.  However, these experiments were only able to observe cell traction 
forces and cytoskeletal dynamics prior to and following transient stretch, and therefore 
concluded that the rapid depolymerization of actin was coincident with the drop in 
traction forces. This effect was hypothesized to perhaps be the result of catch bonds 
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acting to reinforce the cytoskeleton during loading, which promptly release upon de-
loading during stretch reversal [40]. 
Observation during long duration stretches.  The functionality of our 
experimental setup enabled us to observe cellular traction force dynamics during stretch 
application, while substrate strain was actively changing.  These measurements showed 
that the sub-baseline traction forces observed following transient stretch are initiated at 
the onset of strain reversal.  For all but one cell tested, strain energy decreased 
significantly in the vicinity of strain reversal, and continued to decrease below baseline 
values as the stretch completed.  This shows cellular relaxation to be, in part, a result of 
relatively small changes in strain dynamics and not only due to the dramatic physical 
forcing of more rapid stretch application and release.  The global nature of this response 
is made clear by noting that the strain energy dynamics for the vast majority of cell-
attached posts were consistent across the entire cell.  This change in strain energy 
imparted to the mPAD substrate displays a hysteresis that is characteristic of the response 
of a viscoelastic material to applied stretch, although the energy loss indicated by the area 
contained within the loop varied greatly from cell to cell.   
Our experiments also revealed a significant degree of variability in the cellular 
response to increasing substrate strain.  While a subset of the cells tested exhibited 
behavior that was consistent with the catch bond theory proposed by Fredberg et al.[40]: 
an elastic reinforcement of traction forces, presented as increasing whole cell strain 
energy; many cells displayed a more passive response to increasing substrate strain.  
These cells appeared to reach a “plastic limit” following an initial elastic response, after 
which traction forces remained relatively constant or even decreased while substratestrain 
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was still increasing.  Spatial analysis revealed that relative energy changes associated 
with both response modes were uniform across the entire cell.   Given that contractile 
force is generated through relative motion of actin fibers, the ability of a cell to, 
following an initial increase, virtually maintain the magnitude and spatial orientation of 
its traction forces during application of global strain is a surprising result.  This apparent 
transition in cytoskeletal tension may indicate that the depolymerization response 
observed following stretch can occur during stretch, even before the reversal of strain 
direction that ultimately facilitates a release in tension.  While typical immunostaining 
protocols that require fixation would likely be disrupted on a flexible substrate, the use of 
cells genetically modified to express fluorescent actin fibers would allow for 
characterization of actin dynamics during applied stretch.  
Previous studies by Hirata et al. found that exposure to large sustained uniaxial 
stretch of 50% magnitude for 30s induced actin polymerzation at focal adhesions in a 
zyxin and force dependent manner in human foreskin fibroblasts, and was reversible in 
response to decreased tension [41].   Consistent with these findings, zyxin, which 
regulates actin polymerization at focal adhesions in response to changes in tension, could 
play a role in actin depolymerization following strain reversal (tension release).  
However, the recruitment of actin found during applied stretch seems to contradict our 
findings that BPASMCs can begin to relax and decrease force generation in response to a 
biaxial stretch, indicating that the action of zyxin may be overridden by global changes in 




Sustained stretch.  When exposed to a sustained stretch, cellular traction forces again 
showed the relaxation response that was previously observed for some cells during 
increasing strain, and this response continued while maximum substrate strain was 
maintained.  Previous experiments that measured the concentration of intracellular 
calcium demonstrated an increase in intracellular calcium in response to both 
homogeneous [42] and inhomogeneous [43] stretches in fibroblasts and endothelial cells, 
respectively.  Increased intracellular calcium is well known to facilitate increased 
contraction (Section 1.1.2).  Our results demonstrating the relaxation response to a 
sustained stretch may indicate that the influx of calcium observed in response to stretch in 
other cell types is ineffective at increasing contractility during global stretch. This 
supports the hypothesis that global cytoskeletal disruption is the likely driving force 
behind stretch induced relaxation of traction forces.         
Rho-V14 expression.  While it has been shown that Rho, and also constitutively active 
Rho-V14, has significant affects on stress fiber organization and remodeling associated 
with cyclic stretching [44], our  experiments using Rho-V14 expressing BPASMCs did 
not show a significant difference in traction force response during a single applied stretch 
as compared to controls.  This is in contrast to changes in traction forces in response to 
more rapid ~5s stretches, where Rho-V14 expressing cells exhibited a significantly 
smaller decrease in whole cell strain energy as compared to controls.  While 
constitutively active Rho would certainly lead to increased force generation, as seen in 
microtissues (Copeland, Liu, Zhao, Chen and Reich, in preparation), Rho-V14 expression 
did not cause an obvious increase in forces imparted to microposts.  This is likely due the 
reduced ability of single BPASMCs to spread on mPADS that was observed.  Given that 
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the response of Rho-V14 expressing microtissues to applied stretch was not significantly 
different from controls, despite an overall increase in force generation, the difference in 
response to 5s stretches on mPADs may instead be a result of reduced spreading area.  
Reduced spreading area may cause an increase in stress fiber overlap across the cell that 
renders the cytoskeleton more resistant to short duration stretching forces, thereby 
increasing the strain a cell is able to endure prior to the onset of force-induced 
remodeling.       
Cell pairs.  Stretch experiments performed on patterned cell pairs demonstrated 
that while cell-cell interaction does not alter the viscoelastic behavior of cells in response 
to stretch, it does result in a degree of synchronization in the dynamic response between 
the two cells.  As well, the ability to measure cell-cell forces present in these pair 
configurations during applied stretch showed that cell-cell adhesions remain intact and 
under tension during the cytoskeletal remodeling associated with exposure to stretch, and 
that forces generated at cell-cell adhesions are regulated synchronously with traction 
forces at cell-substrate adhesions.  Common regulation of cell-cell and cell-substrate 
forces is consistent with global cellular relaxation caused by cytoskeletal disruption in 
response to stretch. 
Taken together, these results have demonstrated that the responses of cell 
generated contractile forces to applied strain are globally regulated and likely due to cell-






Chapter 5 Local Chemical Stimulation 
 The combined use of techniques for measuring cell generated forces and local 
application of chemical treatment at the cellular level can not only improve experimental 
efficiency, but may provide interesting paths forward in the study of cell-cell interactions.  
Described below is the development of experimental techniques combining micropipette 
facilitated fluid flow (“spritzing”) for controlled delivery of biochemical treatments with 
the aforementioned mPAD system and with a system for measuring the mechanical 
properties of microtissues. 
5.1 Introduction 
 Experimental methods developed to supply biochemical stimulation to controlled 
regions of two dimensional cell culture provide a useful means of probing biological 
systems.  These methods often make use of micropipettes [45-47].  These devices allow 
for controlled delivery of biochemical solution to regions of culture down to the single 
cell level.  Combining these techniques with optical microscopy enables experiments 
where single cell responses can be observed in real time without exposing cells in the 
surrounding culture, which are not under observation, to the desired treatment. This 
allows multiple cells to be sequentially exposed to treatment, while each is under high-
magnification observation. The increased experimental efficiency made capable by these 
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setups is particularly important when, for example, high value cell lines or samples that 
are difficult to prepare are being studied.  In these cases, unobserved exposure to 
treatment renders the bulk of the substrate unusable for further data collection.                      
Microfabricated devices used in our lab allow for real time measurement of force 
generation by single cells, via mPADS, or single microtissues, via µTUGs [48].  In both 
cases, the cell or tissue under observation is located on a PDMS substrate that contains 
many cells or microtissues that are suitable for experimentation, all sharing a common 
bulk media bath. Hence, biochemical treatment through supplementation directly into the 
media bath will treat all available cells/tissues simultaneously.  I have demonstrated the 
combined use of a local chemical stimulation technique termed “micropipette spritzing” 
with mPAD and µTUG devices in order to more efficiently treat and observe single cells 
and microtissues.  In addition, I have shown how this technique can be used to selectively 
manipulate cells in culture on mPADs in order to create physical stimulus through cell-




 Micropipettes (TW-150F-4, World Precision Instruments) were pulled using a 
two stage Kopf 720 Needle Pipette Puller (Kopf Instruments).  This puller operates by 
securing a single pipette held vertically at each end, with a heating element located 
around the center.  As the element heats, a weight located where the bottom end of the 
pipette was secured draws the lower half of the pipette downward a fixed distance.  The 
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puller was then set to the next heat value, or “stage”, and taken through the same process.  
Pipettes of the desired size required 4 heating stages.  The first heat setting is used for the 
first stage of pulling, and the final 3 settings are used while repeating the 2
nd
 stage 
process of pulling until the two pipette halves separate.   Pipettes with tips approximately 
50 µm in diameter, were obtained using heat value dial settings of 8.4, 6.8, 6.8, and 6.4.  
For tips 20 µm in diameter, heating values of 8.4, 6.8, 6.8, and 6.8 were used.  
 
 
5.2.2 Experimental Setup 
 
Figure 5.1: Schematic diagram of micropipette spritzing experimental setup being used 
for single cell treatment on mPADs.  
 
 A custom built platform mounted onto the microscope stage supports two micro-
manipulators that in turn hold mounting devices for the micropipettes.  The manipulator 
setup allowed for precise control of each micropipette, independent of each other and the 
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microscope stage.   Vacuum tubing connects each pipette to its own syringe pump for 
independent control of fluid flow (Figure 5.1).  Precise control of the treatment region 
(the flow plume between the pipettes), required that the user be able to observe the flow 
edges.  In order to visualize the flow plume, the incoming drug supplemented media did 
not contain serum.  The absence of serum caused a sufficient index of refraction 
difference between the inflowing media and the bath for visualization using phase 
contrast microscopy.  A 1 ml syringe was typically used for the inflow solution in order 
to conserve reagents.  In order to remove as much air as possible from the system, the 
outflow syringe, tubing, and pipette were all loaded with un-supplemented media, 
containing no serum or antibiotics.  It was important to make sure that all syringes, lines, 
and pipettes were free of air bubbles in order to reduce lag when controlling the flow.   
Once loaded, pipettes were raised as high as possible and positioned for maximum 
downward angle.  An angle of ~45 degrees ensured that inflowing solution was directed 
downward and would contact the base of the substrate before traveling to the outflow 
pipette.  Using a 4x objective, the pipette tips were located and positioned just above the 
media surface before changing to the 10x objective.  Tips were then moved to a region 
above the substrate that was far from the cells to be treated.  The outflow pipette was 
moved to just below the media surface with the flow rate set high (~9000 µl/hr).  Next, 
the inflow pipette, with its syringe pump still off, was lowered directly in front of the 
outflow pipette.  Once contact with media was made, the high rate of outflow ensured 
any solution leaking out of the inflow was immediately removed from the bath.  Flow 
rates were then adjusted to the lowest possible rate that produced a controllable flow 
plume.  Typical rates were 10-50µ/hr for the inflow and 100-500µl/hr for the outflow.  
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When not flowing for treatment, tips were left very close together with the outflow at an 
“idle” rate of 200µl/hr to account for any remnant leakage from the inflow pipette.  With 
the pipette tips submerged and ready for use, a suitable construct for the device and 
experiments being used was selected and imaged in order to establish a baseline 
measurement.  With the pipette tips still a few hundred microns from the construct of 
interest, flow was initiated and given time to stabilize.  The microscope stage was then 
adjusted to bring the treatment area into view, and the pipette tips were slowly moved 
using the micro-manipulators until they were in place for the desired treatment.  The 
cellular construct and flow plume were imaged using the 10x objective to document the 
flow position (Figure 5.2), after which the construct under treatment was imaged over 








Figure 5.2: Phase contrast image of a spritzing experiment. (A) Phase contrast image 
showing flow plume between the inflow (left) and outflow (right) pipettes. (B) Detailed 
schematic indicating treatment fluid flow plume and direction indicated in grey, ambient 
bath fluid flow is indicated by red arrows.  Cells cultured on mPAD surface are indicated 






In order to characterize the flow field generated by the micropipette system, 
experiments performed by David Hunter in the Tung lab measured the relative 
conductance between a probe located in the inflow pipette and one located in the bath 
using a flow solution of 0.1M NaCl and a bath of de-ionized (DI) water (Figure 5.3 A).  
The bath probe was moved relative to the edge of the visible flow (Figure 5.3 A, solid 
black line), and the relative conductance was measured.  This was performed at five 
different distances away from the inflow pipette, designated by the colored dashed lines 
in Figure 5.3 A.  The plot in Figure 5.3 B shows traces of conductance versus the distance 
from the flow edge, designated by x=0.  Positive x values are when the probe was inside 
the flow, while for negative values the probe is in the bath, outside the flow.  The 
distances from the inflow pipette are represented by the trace color, corresponding to the 
dashed lines in Figure 5.3A.  The data are in agreement with the error function solution to 
the diffusion equation: 
















Figure 5.3: Spritzing flow characterization.  (A) Phase contrast image showing flow of 
NaCl from the inflow pipette (bottom) to the outflow piipette (top).  Probes for measuring 
relative conductance are denoted by the circuit schematic.  Bath probe distances are 
denoted by dashed lines, solid black line represents flow edge. (B) Plot of relative 
conductance vs. probe distance from inflow pipette with associated error function it. Flow 









5.3.1 Single Cell Treatment: Blebbistatin 
The contraction inhibitor blebbistatin (described previously) was used to 
demonstrate biochemical treatment of single cells using the described experimental setup.    
 
 
Figure 5.4: Force vector plot at t = 0s (A) and t = 980s (B).  Relative change in whole cell 
strain energy vs. time for a single BPASMC treated with blebbistatin via media 






Figure 5.2 shows the controlled treatment region created by the micropipette 
system.  Inside the flow region is a single BPASMC adhered to the underlying mPAD. 
Figure 5.4 A and B are force vector maps for the cell treated via spritzing before and after 
980s of exposure to treatment, respectively. Figure 5.4 C shows a plot of the relative 
change in whole cell strain energy vs. time for two cells. The blue trace represents a cell 
that was exposed to blebbistatin treatment via supplementation to the entire media bath 
containing the mPAD (image not shown).  The red trace represents the cell pictured in 
Figure 5.2, which was treated using the spritzing system without exposing the rest of the 
mPAD culture to blebbistatin treatment. This data shows that the spritzing system is 
capable of drug delivery at rates comparable to standard media replacement methods, and 
can be used to treat single cells under observation without treating unobserved cells that 







5.3.2 Trypsin Manipulation of Cell pairs 
 
 
Figure 5.5: Testing the precision of trypsin flow using sprtizing system.  (A) Phase 
contrast image showing flow edge and proximity to a nearby BPASMC.  Vector maps 
and whole cell strain energy values at t = 0 (B), and after 14 minutes of trypsin flow (C).  
(D) Phase contrast image showing as cell was moved into the flow.  Vector maps show 
cell detachment within 16s of exposure (E),(F). 
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 Trypsin-EDTA is commonly used in cell culture in order to remove adherent cells 
from their substrate.  Trypsin is a protease commonly found in the digestive systems of 
many vertebrates that breaks the integrin binding responsible for cell adhesion.  Because 
Ca2+/Mg2+ ions present in culture medium inhibit the action of Trypsin, a combination 
of Trypsin and the chelating agent Ethylenediaminetetraacetic acid (EDTA) is used to 
disrupt cell-substrate adhesions.  With the goal of using localized Trypsin treatment to 
selectively manipulate cell-substrate adhesions on mPADs, we performed a control 
experiment to test the locality of Trypsin flow using the spritzing system.  Figure 5.6 
shows that bringing the visible flow of trypsin within 40 μm of an adherent BPASMC 
(A) has no affect on the cell’s attachment to the mPAD substrate following 14 minutes of 
active flow (B), (C).  However, once the cell is moved into the visible flow (Figure 5.6 
D), detachment from the mPAD rapidly occurs, visible here as a loss of traction forces 
imparted by the cell to the substrate after only 16 s of treatment (D), (E).   
 In combination with techniques previously described to culture pairs of 
BPASMCs on mPADs, the spritzing system was used to alter the cell-substrate adhesion 
of one cell in a cell pair cultured on an mPAD substrate.  Following disruption, the 
traction force response of the untreated cell was measured.  Determination of cell-cell 
force (Section 2.3.3) showed that cell-cell force decreased in response to disruption of 
cell-substrate adhesions of one cell in the pair.  This decrease in cell-cell force was 




Figure 5.6: (A) phase contrast image showing two cells in a pair configuration and the 
Trypsin-EDTA treatment flow plume.  Phase contrast image showing trypsinisation of 
one cell in the pair after 22s of treatment flow. Force vector maps, including the cell-cell 
force, for the untreated cell (red outline) and the treated cell (green outline) prior to 
treatment (C), and following treatment (D).  (E) Total cell strain energy of the untreated 
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cell (red), and cell-cell force (blue) in response to trypsin treatment.  Treatment onset 
indicated by vertical arrow. 
5.3.3 Microtissues 
 The use of micropipette spritzing was also demonstrated in conjunction with 
microfabricated devices designed to study the mechanics of micron-scale tissue 
constructs, termed μTUGs [48].  These devices facilitate the formation of arrays of 
micron-scale tissues that of consist of hundreds of cells and extra cellular matrix (ECM).  
To demonstrate the spritzing technique for chemical treatment of a single tissue construct 
within the larger μTUG device, Hoechst dye was used to stain the nuclei of cells within a 















Figure 5.7: Hoechst dye labeling of cell nuclei in a single microtissue within a TUG 
device.  A microtissue before (A) and after (B) 15 minutes of exposure to treatment.  (C) 
Neighboring tissue is unexposed following treatment. 
 
Further experiments demonstrating the use of the spritzing setup in conjunction 
with μTUG devices were performed using trypsin-EDTA to selectively disrupt cell-
matrix adhesions within single tissues.  In two examples shown (Figures 5.9, 5.10), cells 
within the microtissue become detached from the ECM and cluster in un-spread 
morphologies compared to the smooth appearance of intact tissue observed prior to 







Figure 5.8: Phase contrast images over time of a single microtissue exposed to trypsin 










Figure 5.9: Phase contrast images over time of a single microtissue exposed to trypsin 








 Experiments combining microfabricated devices with a micropipette “spritzing” 
technique used for application of local chemical stimulation were performed.  These 
experiments demonstrated the functionality of the setup through exposure of single 
BASMCs cultured on mPADs to treatment with the contraction inhibitors blebbistatin 
and Y-27632, resulting in decreases in whole cell strain energy imparted to the 
microposts by the cells.  Direct comparison between the time course of blebbistatin 
treatment using the spritzing set up and that of using bath media replacement showed that 
local treatment provided a rate of exposure that was comparable with media replacement.  
This was expected since the concentration of blebbistatin used during the media 
replacement experiments was the same as that used in the inflow solution in the spritzing 
experiments.   As well, local delivery of Hoechst dye, which labels DNA in the cell 
nucleus, was demonstrated on μTUG devices through selective treatment of a single 
microtissue within the device without exposing neighboring tissues to treatment.  This 
same technique was used to selectively treat single microtissues with trypsin-EDTA, 
which could enable paired measurements of tissue mechanics for intact and “de-
cellularized” tissues [49].  The ability to expose single cells or constructs within a 
microfabricated device that contains a bulk media bath for cell culture will allow for 
increased experimental efficiency when observations of dynamic effects in real time are 
desired.  By allowing for simultaneous treatment and observation, single cells and 
constructs that would otherwise be “lost” due to unobserved treatment via media bath 
replacement will now be available for observation. 
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Cell-cell contacts are critical to tissue formation, maintenance, and repair [50], and are 
also sites of active force generation and transmission  [51].  It is therefore critical to 
further our understanding of how cells sense and respond to forces imposed through cell-
cell interaction.  Local chemical stimulation of one cell within a cell pair configuration, 
where two cells are in visible contact with each other, provided a means to investigate the 
traction force response of the untreated cell to changes imposed through cell-cell 
interactions.  Experiments were performed using local treatment with Trypsin-EDTA to 
partially disrupt cell-substrate adhesions for one cell in a cell pair, and the resulting 
change in cell-cell force and contractility of the untreated cell was measured.  These 
results showed that forced cell-substrate detachment for one cell in a pair subsequently 
caused a drop in force generation at cell-cell adhesions.  The observed drop in cell-cell 
force in turn caused changes in traction force orientation and magnitude in the 
neighboring, untreated cell; demonstrating how force transduction at cell-cell contacts 
can affect cell-substrate force generation.   
The combination of force sensing culture substrates and the ability to apply controlled 










Chapter 6 Conclusion 
Our growing knowledge of the importance of physical phenomena in the 
regulation and proper functioning of biological systems is driving the development of 
specialized tools and methodologies that enable precise measurements of cellular activity 
and mechanical properties.  The ability to selectively manipulate the in vitro environment 
and to apply specific stimuli to biological cells are powerful tools for the elucidation of 
how physical interactions can lead to pathological conditions. 
By combining a microfabricated device that enabled measurement of cell 
generated forces with controlled interaction of cardiac fibroblasts and myocytes through 
the fabrication of model cardiac tissues, specific experiments designed to define the role 
of mechanical interactions in impaired cardiac tissue function were able to be performed.  
Slowing of electrical signal conduction velocity (CV) due to heterocellular coupling 
between cardiac fibroblasts (CFs) and cardiac myocytes was found to be the result of 
mechanical coupling between these two cells types.  Chemical and genetic interventions 
that were shown to directly alter CF force generation also served to influence CV in ways 
consistent with the hypothesis that the contractile forces generated by CFs were causing 
the observed CV slowing.  Further chemical and genetic intervention was applied to the 
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model tissue system in order to disrupt the proposed coupling mechanism, which, along 
with confirmation that CF contractility was unaffected by these treatments, was found to 
be N-Cadherin mediated transfer of mechanical force generated by CFs to the myocyte 
membranes, opening stretch activated channels.  The opening of these channels likely 
causes unregulated depolarization of myocyte membrane potential, which can lead to 
dangerous arrhythmias in vivo.  These experiments demonstrate how mechanical forces 
can regulate cellular function, and how understanding of the exact mechanisms can be 
gained through the combined use of a controlled microenvironment and microfabricated 
tools.    
An enhanced version of the mPAD device used for measuring cell generated 
contractile forces was developed in order to apply global stretch stimulation to arterial 
smooth muscle cells.  Flexible membranes containing micropost arrays were fabricated 
from PDMS and stretched in a custom culture chamber, enabling real time observation of 
traction force dynamics during stretch.  These experiments revealed that while the 
response of single cells to applied stretch was in general viscoelastic, cell response during 
increasing strain could vary greatly.  Previous experiments using similar systems [39, 40] 
that observed cellular response prior to and following transient stretch had attributed the 
large drop in traction forces following stretch to be caused by the dramatic release in 
tension associated with the un-stretch portion of the protocol.  Our data taken during 
stretch revealed that relaxation of forces could occur well before stretch release.  While a 
subset of the cells tested exhibited increased force generation in response to stretch, 
others showed maintained or even decreasing forces while substrate strain was still 
increasing.  The mechanisms behind these differing responses could play a critical role in 
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the progression of mechanically mediated arterial diseases such as fibrosis and vascular 
hypertension.  To this end, experiments using our system could be performed to 
determine if the response to stretch is altered in diseased smooth muscle cells, which 
would then allow for genetic and/or chemical intervention to determine the mechanism 
responsible for any observed differences.   
Finally, the combined use of local chemical stimulation with the mPAD devices 
was shown to enable single cell manipulation and determination of cell-cell forces in cell 
pairs.  Similar experiments could be used to investigate wound healing mechanisms 
through controlled formation, via trypsin treatment, of model wounds in cell monolayers 
on mPADs, where dynamics in force generation during model wound healing could be 
observed.   
The results described in this work demonstrate the value of microfabricated 
devices for investigating physical cell-cell and cell-substrate interactions, and how 
insights gained from furthering our understanding of these interactions provide critical 
information necessary for moving towards treatments for pathologies that involve 
mechanical interactions in biological systems. 
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